Section 5 PE Tables - Results from the 2024 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ

250602

Table 5.1A – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2023 and 2024
Substance	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE DISORDER	48,464	48,351	2,192	2,024	46,272	46,327	9,228	9,056	37,044	37,271
DRUGS	27,153	28,184	1,780	1,705	25,373	26,480	6,113	6,210	19,260	20,269
Marijuana	19,164^a	20,585	1,223	1,219	17,941^a	19,366	5,634	5,536	12,308^a	13,830
Cocaine	1,256	1,211	45	14	1,212	1,197	189	280	1,023	917
Heroin	587	496	*	9	587	486	17	33	570	453
Hallucinogens	428	433	59	83	369	350	132	102	237	248
Inhalants	304	352	78	84	226	269	39	82	187	187
Methamphetamine	1,784	1,571	23	9	1,761	1,562	71	96	1,690	1,465
Prescription Psychotherapeutics	7,889	7,628	598	524	7,292	7,104	769	805	6,523	6,300
Pain Relievers	5,344	4,952	316	286	5,027	4,666	392	341	4,636	4,325
Prescription Opioids	4,708	4,596	230	262	4,478	4,334	343	314	4,135	4,020
Stimulants	1,718	1,846	244	191	1,474	1,655	315	411	1,158	1,243
Tranquilizers or Sedatives	2,256	2,096	140	119	2,116	1,976	222	239	1,894	1,737
Tranquilizers	1,747	1,497	89	84	1,659	1,413	162	194	1,497	1,219
Sedatives	869	812	72	44	797	767	77	90	720	677
Opioids¹	5,043	4,822	230	267	4,813	4,555	347	335	4,466	4,220
Central Nervous System Stimulants	4,322	4,266	268	210	4,053	4,056	525^b	722	3,529	3,334
ALCOHOL	28,859	27,913	757	775	28,103	27,138	5,123	5,029	22,980	22,108
BOTH DRUGS AND ALCOHOL	7,549	7,746	345	456	7,204	7,290	2,008	2,183	5,197	5,106
DRUGS ONLY (NO ALCOHOL USE DISORDER)	19,604	20,438	1,435	1,249	18,169	19,190	4,105	4,027	14,064	15,163
ALCOHOL ONLY (NO DRUG USE DISORDER)	21,311	20,167	412	319	20,899	19,848	3,115	2,846	17,784	17,002
NO SUBSTANCE USE DISORDER	234,994^b	239,891	23,723	23,928	211,270^b	215,964	24,805^b	25,890	186,465^b	190,074
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.1B – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 12 or Older; by Age Group, Percentages, 2023 and 2024
Substance	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE DISORDER	17.1	16.8	8.5	7.8	18.0	17.7	27.1	25.9	16.6	16.4
DRUGS	9.6	9.8	6.9	6.6	9.9	10.1	18.0	17.8	8.6	8.9
Marijuana	6.8	7.1	4.7	4.7	7.0	7.4	16.6	15.8	5.5^a	6.1
Cocaine	0.4	0.4	0.2	0.1	0.5	0.5	0.6	0.8	0.5	0.4
Heroin	0.2	0.2	*	<0.1	0.2	0.2	<0.1	0.1	0.3	0.2
Hallucinogens	0.2	0.2	0.2	0.3	0.1	0.1	0.4	0.3	0.1	0.1
Inhalants	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1
Methamphetamine	0.6	0.5	0.1	<0.1	0.7	0.6	0.2	0.3	0.8	0.6
Prescription Psychotherapeutics	2.8	2.6	2.3	2.0	2.8	2.7	2.3	2.3	2.9	2.8
Pain Relievers	1.9	1.7	1.2	1.1	2.0	1.8	1.2	1.0	2.1	1.9
Prescription Opioids	1.7	1.6	0.9	1.0	1.7	1.7	1.0	0.9	1.9	1.8
Stimulants	0.6	0.6	0.9	0.7	0.6	0.6	0.9	1.2	0.5	0.5
Tranquilizers or Sedatives	0.8	0.7	0.5	0.5	0.8	0.8	0.7	0.7	0.8	0.8
Tranquilizers	0.6	0.5	0.3	0.3	0.6	0.5	0.5	0.6	0.7	0.5
Sedatives	0.3	0.3	0.3	0.2	0.3	0.3	0.2	0.3	0.3	0.3
Opioids¹	1.8	1.7	0.9	1.0	1.9	1.7	1.0	1.0	2.0	1.9
Central Nervous System Stimulants	1.5	1.5	1.0	0.8	1.6	1.5	1.5^a	2.1	1.6	1.5
ALCOHOL	10.2	9.7	2.9	3.0	10.9	10.3	15.1	14.4	10.3	9.7
BOTH DRUGS AND ALCOHOL	2.7	2.7	1.3	1.8	2.8	2.8	5.9	6.2	2.3	2.2
DRUGS ONLY (NO ALCOHOL USE DISORDER)	6.9	7.1	5.5	4.8	7.1	7.3	12.1	11.5	6.3	6.7
ALCOHOL ONLY (NO DRUG USE DISORDER)	7.5^a	7.0	1.6	1.2	8.1^a	7.6	9.2^a	8.1	8.0	7.5
NO SUBSTANCE USE DISORDER	82.9	83.2	91.5	92.2	82.0	82.3	72.9	74.1	83.4	83.6
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.2A – Substance Use Disorder Severity Level for Specific Substances in Past Year: Among People Aged 12 or Older; Numbers in Thousands, 2023 and 2024
Substance	Any Substance Use Disorder (2023)	Any Substance Use Disorder (2024)	Severity Level
Substance	Any Substance Use Disorder (2023)	Any Substance Use Disorder (2024)	Mild Substance Use Disorder (2023)	Mild Substance Use Disorder (2024)	Moderate Substance Use Disorder (2023)	Moderate Substance Use Disorder (2024)	Severe Substance Use Disorder (2023)	Severe Substance Use Disorder (2024)
SUBSTANCE USE DISORDER	48,464	48,351	27,075	27,001	10,980	11,031	10,409	10,319
DRUGS	27,153	28,184	15,187	15,508	6,230	6,881	5,736	5,795
Marijuana	19,164^a	20,585	10,625	11,188	5,088	5,747	3,450	3,650
Cocaine	1,256	1,211	423	498	307	257	526	457
Heroin	587	496	76	66	57	83	455	347
Hallucinogens	428	433	321	291	85	99	22	42
Inhalants	304	352	200	209	24	72	80	71
Methamphetamine	1,784	1,571	495^a	257	285	307	1,004	1,006
Prescription Psychotherapeutics	7,889	7,628	5,512	5,330	1,320	1,214	1,057	1,084
Pain Relievers	5,344	4,952	3,790	3,509	852	710	702	734
Prescription Opioids	4,708	4,596	3,312	3,193	700	681	697	722
Stimulants	1,718	1,846	1,238	1,208	267	375	213	263
Tranquilizers or Sedatives	2,256	2,096	1,469	1,406	440	308	347	382
Tranquilizers	1,747	1,497	1,102	942	371	229	274	326
Sedatives	869	812	614	546	138	154	118	112
Opioids¹	5,043	4,822	3,246	3,152	746	738	1,051	932
Central Nervous System Stimulants	4,322	4,266	1,952	1,781	729	871	1,641	1,613
ALCOHOL	28,859	27,913	16,925	16,567	6,322	5,975	5,613	5,370
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.2B – Substance Use Disorder Severity Level for Specific Substances in Past Year: Among People Aged 12 or Older; Percentages, 2023 and 2024
Substance	Any Substance Use Disorder (2023)	Any Substance Use Disorder (2024)	Severity Level
Substance	Any Substance Use Disorder (2023)	Any Substance Use Disorder (2024)	Mild Substance Use Disorder (2023)	Mild Substance Use Disorder (2024)	Moderate Substance Use Disorder (2023)	Moderate Substance Use Disorder (2024)	Severe Substance Use Disorder (2023)	Severe Substance Use Disorder (2024)
SUBSTANCE USE DISORDER	17.1	16.8	9.6	9.4	3.9	3.8	3.7	3.6
DRUGS	9.6	9.8	5.4	5.4	2.2	2.4	2.0	2.0
Marijuana	6.8	7.1	3.7	3.9	1.8	2.0	1.2	1.3
Cocaine	0.4	0.4	0.1	0.2	0.1	0.1	0.2	0.2
Heroin	0.2	0.2	<0.1	<0.1	<0.1	<0.1	0.2	0.1
Hallucinogens	0.2	0.2	0.1	0.1	<0.1	<0.1	<0.1	<0.1
Inhalants	0.1	0.1	0.1	0.1	<0.1	<0.1	<0.1	<0.1
Methamphetamine	0.6	0.5	0.2^a	0.1	0.1	0.1	0.4	0.3
Prescription Psychotherapeutics	2.8	2.6	1.9	1.8	0.5	0.4	0.4	0.4
Pain Relievers	1.9	1.7	1.3	1.2	0.3	0.2	0.2	0.3
Prescription Opioids	1.7	1.6	1.2	1.1	0.2	0.2	0.2	0.3
Stimulants	0.6	0.6	0.4	0.4	0.1	0.1	0.1	0.1
Tranquilizers or Sedatives	0.8	0.7	0.5	0.5	0.2	0.1	0.1	0.1
Tranquilizers	0.6	0.5	0.4	0.3	0.1^a	0.1	0.1	0.1
Sedatives	0.3	0.3	0.2	0.2	<0.1	0.1	<0.1	<0.1
Opioids¹	1.8	1.7	1.1	1.1	0.3	0.3	0.4	0.3
Central Nervous System Stimulants	1.5	1.5	0.7	0.6	0.3	0.3	0.6	0.6
ALCOHOL	10.2	9.7	6.0	5.7	2.2	2.1	2.0	1.9
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.3A – Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Drug Use Disorder (2023)	Drug Use Disorder (2024)	Alcohol Use Disorder (2023)	Alcohol Use Disorder (2024)	Substance Use Disorder (2023)	Substance Use Disorder (2024)
TOTAL	27,153	28,184	28,859	27,913	48,464	48,351
12-20¹	3,869	3,654	2,109	1,998	5,082	4,627
21 or Older¹	23,284	24,530	26,750	25,915	43,381	43,724
12-17	1,780	1,705	757	775	2,192	2,024
12-13	196	212	37	55	219	238
14-15	646^b	468	272	212	789^b	550
16-17	938	1,025	448	509	1,183	1,235
18 or Older	25,373	26,480	28,103	27,138	46,272	46,327
18-25	6,113	6,210	5,123	5,029	9,228	9,056
18-20	2,089	1,949	1,353	1,223	2,891	2,603
21-25	4,024	4,261	3,770	3,807	6,337	6,453
26 or Older	19,260	20,269	22,980	22,108	37,044	37,271
26-49	12,559	13,498	14,585	13,768	23,295	23,469
26-29	2,981	3,161	2,908	2,635	4,901	4,882
30-34	2,994	3,263	3,646^a	3,118	5,621	5,417
35-39	2,811	2,931	3,023	3,169	5,065	5,234
40-44	1,918	2,178	2,837	2,700	4,216	4,281
45-49	1,855	1,966	2,171	2,146	3,493	3,654
50 or Older	6,701	6,771	8,395	8,340	13,748	13,802
50-54	1,547	1,607	1,934	1,797	3,089	2,964
55-59	1,259	1,389	1,837	1,875	2,872	3,007
60-64	1,661	1,506	1,942	1,778	3,176	3,021
65 or Older	2,235	2,270	2,682	2,890	4,610	4,809
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ The 12-20 and 21 or older rows are included because they are the underage and legal age groups for alcohol. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.3B – Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Drug Use Disorder (2023)	Drug Use Disorder (2024)	Alcohol Use Disorder (2023)	Alcohol Use Disorder (2024)	Substance Use Disorder (2023)	Substance Use Disorder (2024)
TOTAL	9.6	9.8	10.2	9.7	17.1	16.8
12-20¹	10.2	9.5	5.5	5.2	13.4^a	12.0
21 or Older¹	9.5	9.8	10.9	10.4	17.7	17.5
12-17	6.9	6.6	2.9	3.0	8.5	7.8
12-13	2.5	2.6	0.5	0.7	2.8	2.9
14-15	7.1^a	5.3	3.0	2.4	8.6^b	6.2
16-17	10.6	11.4	5.1	5.7	13.4	13.7
18 or Older	9.9	10.1	10.9	10.3	18.0	17.7
18-25	18.0	17.8	15.1	14.4	27.1	25.9
18-20	17.2	15.5	11.1	9.7	23.8^a	20.7
21-25	18.4	19.0	17.2	17.0	29.0	28.8
26 or Older	8.6	8.9	10.3	9.7	16.6	16.4
26-49	12.1	12.8	14.1^a	13.0	22.5	22.2
26-29	16.9	18.1	16.5	15.1	27.9	27.9
30-34	13.2	13.9	16.1^b	13.3	24.8	23.0
35-39	12.1	12.7	13.0	13.7	21.8	22.6
40-44	9.0	9.7	13.4	12.0	19.9	19.1
45-49	9.8	10.2	11.5	11.1	18.5	19.0
50 or Older	5.6	5.6	7.0	6.9	11.5	11.4
50-54	8.3	8.2	10.4	9.1	16.5	15.0
55-59	6.1	7.1	8.9	9.6	14.0	15.4
60-64	7.3	6.7	8.5	7.9	13.9	13.4
65 or Older	3.9	3.8	4.6	4.8	8.0	8.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ The 12-20 and 21 or older rows are included because they are the underage and legal age groups for alcohol. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.4A – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	27,153	28,184	1,780	1,705	25,373	26,480	6,113	6,210	19,260	20,269
SEX
Male	15,375	16,092	680	736	14,695	15,356	3,354	3,315	11,342	12,041
Female	11,778	12,093	1,100	969	10,678	11,124	2,759	2,896	7,919	8,228
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	22,568	23,338	1,236	1,243	21,332	22,095	4,774	4,779	16,558	17,316
AIAN	263	207	14	13	249	195	40	45	209	150
Asian	767	726	54	57	712	669	168	162	545	507
Black or African American	3,953	3,979	252	246	3,701	3,733	979	961	2,722	2,772
NHPI	*	66	2	1	*	65	*	*	*	48
White	16,389	17,245	819	843	15,569	16,402	3,300	3,322	12,269	13,080
Two or More Races	934	1,115	95	84	839	1,030	271	273	568	757
Hispanic or Latino	4,585	4,846	544	462	4,041	4,384	1,339	1,431	2,702	2,953
EDUCATION LEVEL
< High School	da	da	da	da	2,884	2,851	723	714	2,161	2,137
High School Graduate	da	da	da	da	8,442	8,794	2,307	2,227	6,135	6,567
Some College/Associate’s Degree	da	da	da	da	8,885	9,339	2,412	2,430	6,474	6,909
College Graduate	da	da	da	da	5,162	5,496	671	840	4,491	4,656
EMPLOYMENT STATUS
Full-Time	da	da	da	da	11,574	11,633	2,630	2,703	8,944	8,929
Part-Time	da	da	da	da	3,518	3,700	1,597	1,477	1,921	2,223
Unemployed	da	da	da	da	2,318	2,447	763	817	1,555	1,631
Other¹	da	da	da	da	7,964	8,700	1,124	1,214	6,840	7,486
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Drug use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.4B – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	9.6	9.8	6.9	6.6	9.9	10.1	18.0	17.8	8.6	8.9
SEX
Male	11.1	11.4	5.1	5.5	11.7	12.0	19.6	18.9	10.5	10.9
Female	8.1	8.2	8.7	7.6	8.1	8.3	16.3	16.7	6.9	7.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	9.8	10.0	6.5	6.5	10.1	10.3	18.5	18.3	8.9	9.2
AIAN	19.7	15.2	6.0	6.0	22.6	16.9	28.7	28.7	21.7	15.0
Asian	4.4	3.9	3.7	3.8	4.4	3.9	7.6	6.7	3.9	3.4
Black or African American	11.4	11.3	7.0	6.9	11.9	11.8	21.5	20.9	10.2	10.2
NHPI	*	5.3	1.8	0.7	*	5.6	*	*	*	4.8
White	9.6	10.1	6.4	6.7	9.9	10.4	18.7	18.7	8.8	9.3
Two or More Races	15.1	17.2	10.2	8.1	15.9	18.9	24.8	23.8	13.6	17.6
Hispanic or Latino	8.8	8.9	8.0	6.7	8.9	9.2	16.2	16.3	7.3	7.6
EDUCATION LEVEL
< High School	da	da	da	da	11.8	11.9	20.2	20.2	10.3	10.4
High School Graduate	da	da	da	da	12.2	12.5	20.0	18.3	10.6	11.3
Some College/Associate’s Degree	da	da	da	da	11.5	12.0	18.3	18.3	10.1	10.7
College Graduate	da	da	da	da	6.0	6.1	11.7	14.0	5.6	5.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	9.6	9.6	19.0	19.3	8.3	8.3
Part-Time	da	da	da	da	11.2	11.4	19.1	16.8	8.3	9.4
Unemployed	da	da	da	da	20.3	19.0	22.8	22.2	19.2	17.7
Other¹	da	da	da	da	8.5	9.1	13.2	14.4	8.0	8.6
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Drug use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.5A – Marijuana Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	19,164^a	20,585	1,223	1,219	17,941^a	19,366	5,634	5,536	12,308^a	13,830
SEX
Male	11,380	12,389	474	514	10,906	11,875	3,116	3,005	7,790^a	8,869
Female	7,784	8,196	748	705	7,035	7,491	2,518	2,531	4,518	4,961
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	15,948	17,068	827	862	15,121	16,206	4,407	4,261	10,714^a	11,944
AIAN	173	171	10	9	163	162	29	38	134	124
Asian	374	410	35	26	339	384	149	138	190	246
Black or African American	3,020	3,398	179	177	2,841	3,222	950	904	1,890	2,318
NHPI	*	55	*	1	*	54	*	*	*	*
White	11,495	12,168	527	587	10,968	11,581	3,018	2,911	7,950	8,670
Two or More Races	778	866	74	63	704	803	247	256	457	547
Hispanic or Latino	3,216	3,517	396	357	2,820	3,161	1,227	1,275	1,593	1,886
EDUCATION LEVEL
< High School	da	da	da	da	1,775	1,921	648	631	1,127	1,290
High School Graduate	da	da	da	da	6,070	6,719	2,151	1,980	3,919^a	4,739
Some College/Associate’s Degree	da	da	da	da	6,458	6,812	2,214	2,155	4,244	4,656
College Graduate	da	da	da	da	3,638	3,915	620	770	3,019	3,145
EMPLOYMENT STATUS
Full-Time	da	da	da	da	8,993	9,494	2,454	2,462	6,540	7,032
Part-Time	da	da	da	da	2,853	2,902	1,461	1,334	1,392	1,567
Unemployed	da	da	da	da	1,726	2,009	714	738	1,012	1,270
Other¹	da	da	da	da	4,369	4,962	1,005	1,002	3,364	3,960
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Marijuana use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on marijuana use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.5B – Marijuana Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	6.8	7.1	4.7	4.7	7.0	7.4	16.6	15.8	5.5^a	6.1
SEX
Male	8.2	8.8	3.6	3.9	8.7	9.3	18.3	17.1	7.2	8.1
Female	5.4	5.6	5.9	5.6	5.3	5.6	14.8	14.6	3.9	4.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6.9	7.3	4.3	4.5	7.1	7.6	17.1	16.3	5.8	6.3
AIAN	12.9	12.5	4.5	4.1	14.7	14.1	20.4	24.6	13.9	12.4
Asian	2.1	2.2	2.4	1.7	2.1	2.2	6.7	5.8	1.4	1.7
Black or African American	8.7	9.6	5.0	5.0	9.1	10.2	20.8	19.7	7.1	8.6
NHPI	*	4.4	*	0.7	*	4.7	*	*	*	*
White	6.7	7.1	4.1	4.6	7.0	7.3	17.1	16.4	5.7	6.2
Two or More Races	12.6	13.4	8.0	6.1	13.4	14.8	22.6	22.3	11.0	12.7
Hispanic or Latino	6.2	6.4	5.8	5.2	6.2	6.6	14.9	14.5	4.3	4.8
EDUCATION LEVEL
< High School	da	da	da	da	7.3	8.0	18.1	17.8	5.4	6.3
High School Graduate	da	da	da	da	8.7	9.6	18.6^a	16.3	6.8^a	8.1
Some College/Associate’s Degree	da	da	da	da	8.4	8.7	16.8	16.3	6.6	7.2
College Graduate	da	da	da	da	4.2	4.3	10.8	12.9	3.7	3.7
EMPLOYMENT STATUS
Full-Time	da	da	da	da	7.4	7.8	17.7	17.5	6.1	6.6
Part-Time	da	da	da	da	9.0	9.0	17.5	15.2	6.0	6.6
Unemployed	da	da	da	da	15.1	15.6	21.4	20.1	12.5	13.8
Other¹	da	da	da	da	4.7	5.2	11.8	11.9	4.0	4.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Marijuana use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on marijuana use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.6A – Prescription Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	4,708	4,596	230	262	4,478	4,334	343	314	4,135	4,020
SEX
Male	2,273	2,218	84	80	2,189	2,138	163	130	2,026	2,008
Female	2,435	2,378	146	182	2,289	2,196	180	184	2,109	2,012
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,967	3,807	174	189	3,793	3,618	263	239	3,530	3,379
AIAN	46	22	1	4	45	19	*	*	37	13
Asian	144	225	20	9	124	216	10	2	114	214
Black or African American	675^a	428	33	33	642^a	396	49	45	592^a	351
NHPI	*	11	*	*	*	11	*	*	*	7
White	2,897	2,955	111	135	2,786	2,820	169	159	2,617	2,661
Two or More Races	99	165	7	9	91	156	24	23	68	133
Hispanic or Latino	741	789	56	73	685	716	80	75	605	641
EDUCATION LEVEL
< High School	da	da	da	da	848	670	79	64	769	605
High School Graduate	da	da	da	da	1,543	1,613	107	165	1,435	1,448
Some College/Associate’s Degree	da	da	da	da	1,476	1,464	145^a	75	1,331	1,389
College Graduate	da	da	da	da	612	587	12	10	600	577
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,175	1,005	131	73	1,044	932
Part-Time	da	da	da	da	380	509	68	89	312	420
Unemployed	da	da	da	da	339	222	40	47	299	175
Other¹	da	da	da	da	2,584	2,598	104	105	2,480	2,493
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Prescription opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on prescription pain reliever use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.6B – Prescription Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1.7	1.6	0.9	1.0	1.7	1.7	1.0	0.9	1.9	1.8
SEX
Male	1.6	1.6	0.6	0.6	1.7	1.7	1.0	0.7	1.9	1.8
Female	1.7	1.6	1.2	1.4	1.7	1.6	1.1	1.1	1.8	1.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.7	1.6	0.9	1.0	1.8	1.7	1.0	0.9	1.9	1.8
AIAN	3.5	1.6	0.6	1.7	4.1	1.6	*	*	3.8	1.3
Asian	0.8	1.2	1.4	0.6	0.8	1.3	0.5	0.1	0.8	1.5
Black or African American	1.9^a	1.2	0.9	0.9	2.1^a	1.2	1.1	1.0	2.2^a	1.3
NHPI	*	0.9	*	*	*	1.0	*	*	*	0.7
White	1.7	1.7	0.9	1.1	1.8	1.8	1.0	0.9	1.9	1.9
Two or More Races	1.6	2.5	0.8	0.9	1.7	2.9	2.2	2.0	1.6	3.1
Hispanic or Latino	1.4	1.4	0.8	1.1	1.5	1.5	1.0	0.9	1.6	1.6
EDUCATION LEVEL
< High School	da	da	da	da	3.5	2.8	2.2	1.8	3.7	3.0
High School Graduate	da	da	da	da	2.2	2.3	0.9	1.4	2.5	2.5
Some College/Associate’s Degree	da	da	da	da	1.9	1.9	1.1^a	0.6	2.1	2.1
College Graduate	da	da	da	da	0.7	0.7	0.2	0.2	0.7	0.7
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.0	0.8	1.0^a	0.5	1.0	0.9
Part-Time	da	da	da	da	1.2	1.6	0.8	1.0	1.3	1.8
Unemployed	da	da	da	da	3.0^a	1.7	1.2	1.3	3.7^a	1.9
Other¹	da	da	da	da	2.8	2.7	1.2	1.2	2.9	2.9
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Prescription opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on prescription pain reliever use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.7A – Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	5,043	4,822	230	267	4,813	4,555	347	335	4,466	4,220
SEX
Male	2,450	2,344	84	80	2,366	2,263	165	138	2,201	2,126
Female	2,593	2,478	146	186	2,447	2,292	183	197	2,265	2,095
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	4,219	4,006	174	193	4,045	3,813	267	260	3,778	3,553
AIAN	50	24	1	4	48	20	*	*	40	15
Asian	144	225	20	9	124	216	10	2	114	214
Black or African American	721^a	454	33	33	688^a	421	49	47	638^a	375
NHPI	*	16	*	*	*	16	*	*	*	11
White	3,082	3,121	111	139	2,971	2,982	173	178	2,798	2,805
Two or More Races	102	165	7	9	95	156	24	23	71	133
Hispanic or Latino	824	816	56	73	768	742	80	75	688	667
EDUCATION LEVEL
< High School	da	da	da	da	897	702	79	64	817	638
High School Graduate	da	da	da	da	1,697	1,718	108^a	180	1,588	1,538
Some College/Associate’s Degree	da	da	da	da	1,581	1,542	147	80	1,434	1,462
College Graduate	da	da	da	da	639	592	12	10	627	582
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,322	1,042	134	79	1,188	962
Part-Time	da	da	da	da	402	518	68	89	334	429
Unemployed	da	da	da	da	351	270	40	59	311	211
Other¹	da	da	da	da	2,739	2,726	106	107	2,633	2,618
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder. Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.7B – Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1.8	1.7	0.9	1.0	1.9	1.7	1.0	1.0	2.0	1.9
SEX
Male	1.8	1.7	0.6	0.6	1.9	1.8	1.0	0.8	2.0	1.9
Female	1.8	1.7	1.2	1.5	1.9	1.7	1.1	1.1	2.0	1.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.8	1.7	0.9	1.0	1.9	1.8	1.0	1.0	2.0	1.9
AIAN	3.7	1.8	0.6	1.7	4.4	1.8	*	*	4.1	1.5
Asian	0.8	1.2	1.4	0.6	0.8	1.3	0.5	0.1	0.8	1.5
Black or African American	2.1^a	1.3	0.9	0.9	2.2^a	1.3	1.1	1.0	2.4^a	1.4
NHPI	*	1.3	*	*	*	1.4	*	*	*	1.1
White	1.8	1.8	0.9	1.1	1.9	1.9	1.0	1.0	2.0	2.0
Two or More Races	1.7	2.5	0.8	0.9	1.8	2.9	2.2	2.0	1.7	3.1
Hispanic or Latino	1.6	1.5	0.8	1.1	1.7	1.6	1.0	0.9	1.9	1.7
EDUCATION LEVEL
< High School	da	da	da	da	3.7	2.9	2.2	1.8	3.9	3.1
High School Graduate	da	da	da	da	2.4	2.4	0.9	1.5	2.7	2.6
Some College/Associate’s Degree	da	da	da	da	2.1	2.0	1.1	0.6	2.2	2.3
College Graduate	da	da	da	da	0.7	0.7	0.2	0.2	0.8	0.7
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.1	0.9	1.0	0.6	1.1	0.9
Part-Time	da	da	da	da	1.3	1.6	0.8	1.0	1.4	1.8
Unemployed	da	da	da	da	3.1	2.1	1.2	1.6	3.8	2.3
Other¹	da	da	da	da	2.9	2.8	1.2	1.3	3.1	3.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder. Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.8A – Central Nervous System Stimulant Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	4,322	4,266	268	210	4,053	4,056	525^b	722	3,529	3,334
SEX
Male	2,502	2,497	123	107	2,379	2,391	268	372	2,111	2,019
Female	1,820	1,769	145	103	1,674	1,665	256	350	1,418	1,315
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,636	3,589	194	165	3,442	3,424	447	553	2,996	2,871
AIAN	74	20	3	2	72	18	6	1	66	17
Asian	75	101	5	22	71	79	21	30	50	49
Black or African American	365	307	11^a	2	354	305	21	44	333	261
NHPI	*	11	*	*	*	11	*	<1	*	11
White	2,954	2,933	161	133	2,793	2,800	378	450	2,414	2,351
Two or More Races	111^a	216	13	6	97^a	210	20	28	77^a	183
Hispanic or Latino	686	677	75	45	611	632	78^a	169	533	463
EDUCATION LEVEL
< High School	da	da	da	da	540	462	82	79	457	383
High School Graduate	da	da	da	da	1,235	1,403	176	240	1,059	1,162
Some College/Associate’s Degree	da	da	da	da	1,455	1,301	200^a	315	1,255	986
College Graduate	da	da	da	da	824	890	66	87	758	802
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,755	1,663	209^a	310	1,546	1,352
Part-Time	da	da	da	da	524	579	147	134	377	445
Unemployed	da	da	da	da	524	454	68	96	456	358
Other¹	da	da	da	da	1,250	1,360	101^a	182	1,149	1,178
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Central nervous system stimulant use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on central nervous system stimulant use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.8B – Central Nervous System Stimulant Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1.5	1.5	1.0	0.8	1.6	1.5	1.5^a	2.1	1.6	1.5
SEX
Male	1.8	1.8	0.9	0.8	1.9	1.9	1.6	2.1	1.9	1.8
Female	1.3	1.2	1.1	0.8	1.3	1.2	1.5	2.0	1.2	1.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.6	1.5	1.0	0.9	1.6	1.6	1.7	2.1	1.6	1.5
AIAN	5.5	1.5	1.2	0.9	6.5	1.6	4.1	0.8	6.8	1.7
Asian	0.4	0.5	0.3	1.5	0.4	0.5	1.0	1.3	0.4	0.3
Black or African American	1.1	0.9	0.3^a	0.1	1.1	1.0	0.5	1.0	1.3	1.0
NHPI	*	0.9	*	*	*	1.0	*	<0.1	*	1.1
White	1.7	1.7	1.3	1.1	1.8	1.8	2.1	2.5	1.7	1.7
Two or More Races	1.8^a	3.3	1.4	0.6	1.8^a	3.9	1.9	2.4	1.8^a	4.3
Hispanic or Latino	1.3	1.2	1.1	0.7	1.3	1.3	0.9^a	1.9	1.4	1.2
EDUCATION LEVEL
< High School	da	da	da	da	2.2	1.9	2.3	2.2	2.2	1.9
High School Graduate	da	da	da	da	1.8	2.0	1.5	2.0	1.8	2.0
Some College/Associate’s Degree	da	da	da	da	1.9	1.7	1.5^a	2.4	2.0	1.5
College Graduate	da	da	da	da	1.0	1.0	1.1	1.5	0.9	1.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.5	1.4	1.5^a	2.2	1.4	1.3
Part-Time	da	da	da	da	1.7	1.8	1.8	1.5	1.6	1.9
Unemployed	da	da	da	da	4.6	3.5	2.0	2.6	5.6	3.9
Other¹	da	da	da	da	1.3	1.4	1.2^a	2.2	1.4	1.3
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Central nervous system stimulant use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on central nervous system stimulant use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.9A – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)	Aged 12-20¹ (2023)	Aged 12-20¹ (2024)	Aged 21+¹ (2023)	Aged 21+¹ (2024)
TOTAL	28,859	27,913	757	775	28,103	27,138	5,123	5,029	22,980	22,108	2,109	1,998	26,750	25,915
SEX
Male	16,838	16,680	270	255	16,568	16,425	2,557	2,640	14,011	13,785	938	891	15,899	15,790
Female	12,022	11,232	487	520	11,535	10,713	2,566	2,390	8,969	8,323	1,171	1,107	10,851	10,125
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	24,054	22,926	533	562	23,521	22,364	3,934	3,715	19,587	18,648	1,623	1,473	22,431	21,453
AIAN	156	134	5	3	150	130	24	30	126	100	11	14	145	120
Asian	994	1,029	15	*	979	1,016	263	182	716	834	86	56	908	973
Black or African American	3,323	3,368	46	68	3,277	3,300	571	526	2,705	2,773	208	194	3,115	3,174
NHPI	88	98	<1	1	87	97	*	*	68	68	1	*	87	87
White	18,652	17,647	438	446	18,214	17,201	2,856	2,779	15,358	14,422	1,208	1,140	17,444	16,507
Two or More Races	841	650	28	31	813	620	201	169	613	451	109	57	732	593
Hispanic or Latino	4,805	4,987	223	213	4,582	4,774	1,188	1,314	3,393	3,460	486	525	4,319	4,462
EDUCATION LEVEL
< High School	da	da	da	da	2,358	1,946	455	430	1,903	1,516	da	da	2,146	1,730
High School Graduate	da	da	da	da	6,952	6,755	1,522	1,663	5,430	5,092	da	da	6,456	6,293
Some College/Associate’s Degree	da	da	da	da	8,813	8,880	2,176	1,946	6,637	6,933	da	da	8,169	8,334
College Graduate	da	da	da	da	9,980	9,557	970	989	9,010	8,568	da	da	9,979	9,557
EMPLOYMENT STATUS
Full-Time	da	da	da	da	16,016	15,109	2,340	2,520	13,675	12,589	da	da	15,625	14,631
Part-Time	da	da	da	da	3,717	3,497	1,320	1,100	2,397	2,397	da	da	3,269	3,129
Unemployed	da	da	da	da	1,760	1,890	546	531	1,215	1,359	da	da	1,634	1,774
Other²	da	da	da	da	6,610	6,642	917	879	5,693	5,764	da	da	6,222	6,381
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ The aged 12-20 and aged 21+ columns are included because they are the underage and legal age groups for alcohol. ² Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.9B – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)	Aged 12-20¹ (2023)	Aged 12-20¹ (2024)	Aged 21+¹ (2023)	Aged 21+¹ (2024)
TOTAL	10.2	9.7	2.9	3.0	10.9	10.3	15.1	14.4	10.3	9.7	5.5	5.2	10.9	10.4
SEX
Male	12.1	11.8	2.0	1.9	13.2	12.9	15.0	15.0	12.9	12.5	4.8	4.5	13.4	13.0
Female	8.3^a	7.6	3.8	4.1	8.7^a	8.0	15.1	13.7	7.8	7.1	6.3	5.9	8.6	7.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	10.4	9.8	2.8	3.0	11.1^a	10.4	15.3	14.2	10.5	9.9	5.8	5.2	11.0	10.4
AIAN	11.6	9.8	2.3	1.6	13.6	11.3	17.3	19.5	13.1	10.0	3.7	5.4	13.8	10.9
Asian	5.7	5.5	1.0	*	6.1	5.9	11.9	7.6	5.2	5.7	3.6	2.3	6.0	6.0
Black or African American	9.6	9.6	1.3	1.9	10.5	10.4	12.5	11.5	10.2	10.2	4.0	3.7	10.6	10.6
NHPI	7.9	7.9	0.6	1.7	8.5	8.4	*	*	7.6	6.7	0.8	*	8.8	7.9
White	11.0	10.3	3.4	3.5	11.6	10.9	16.2	15.7	11.0	10.3	6.4	6.1	11.5	10.9
Two or More Races	13.6^a	10.0	3.0	2.9	15.4	11.4	18.4	14.7	14.7	10.5	8.1^a	3.9	15.1	11.8
Hispanic or Latino	9.2	9.1	3.3	3.1	10.1	10.0	14.4	15.0	9.1	8.9	4.9	5.1	10.2	10.1
EDUCATION LEVEL
< High School	da	da	da	da	9.6	8.1	12.7	12.2	9.1	7.4	da	da	9.7	7.9
High School Graduate	da	da	da	da	10.0	9.6	13.2	13.7	9.4	8.8	da	da	10.1	9.7
Some College/Associate’s Degree	da	da	da	da	11.4	11.4	16.5	14.7	10.4	10.7	da	da	11.3	11.4
College Graduate	da	da	da	da	11.5	10.6	16.9	16.5	11.2	10.2	da	da	11.5	10.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	13.2	12.5	16.9	18.0	12.8^a	11.7	da	da	13.2	12.4
Part-Time	da	da	da	da	11.8	10.8	15.8^a	12.5	10.3	10.2	da	da	11.8	11.1
Unemployed	da	da	da	da	15.4	14.7	16.3	14.5	15.0	14.7	da	da	16.3	15.6
Other²	da	da	da	da	7.1	6.9	10.8	10.4	6.7	6.6	da	da	6.9	6.9
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ The aged 12-20 and aged 21+ columns are included because they are the underage and legal age groups for alcohol. ² Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.10A – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	48,464	48,351	2,192	2,024	46,272	46,327	9,228	9,056	37,044	37,271
SEX
Male	27,735	28,114	852	859	26,883	27,255	4,857	4,800	22,026	22,455
Female	20,729	20,237	1,340	1,164	19,389	19,073	4,371	4,257	15,018	14,816
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	40,276	39,909	1,520	1,471	38,755	38,438	7,134	6,902	31,621	31,536
AIAN	339	290	17	13	321	278	*	51	265	227
Asian	1,608	1,621	58	59	1,549	1,563	372	318	1,177	1,245
Black or African American	6,116	6,081	264	270	5,851	5,811	1,269	1,204	4,582	4,607
NHPI	*	149	2	1	*	148	*	*	*	114
White	30,382	30,302	1,075	1,021	29,306	29,282	5,041	4,926	24,265	24,355
Two or More Races	1,505	1,465	103	108	1,402	1,358	363	369	1,039	989
Hispanic or Latino	8,188	8,442	671	553	7,517	7,889	2,094	2,154	5,423	5,735
EDUCATION LEVEL
< High School	da	da	da	da	4,534	4,106	968	890	3,566	3,216
High School Graduate	da	da	da	da	13,189	13,171	3,126	3,087	10,062	10,084
Some College/Associate’s Degree	da	da	da	da	14,959	15,551	3,724	3,565	11,235	11,986
College Graduate	da	da	da	da	13,591	13,500	1,410	1,514	12,181	11,986
EMPLOYMENT STATUS
Full-Time	da	da	da	da	23,909	22,752	4,126	4,163	19,784	18,589
Part-Time	da	da	da	da	6,204	6,260	2,390	2,118	3,814	4,142
Unemployed	da	da	da	da	3,306	3,622	1,017	1,080	2,289	2,542
Other¹	da	da	da	da	12,853	13,693	1,696	1,695	11,157	11,998
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.10B – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	17.1	16.8	8.5	7.8	18.0	17.7	27.1	25.9	16.6	16.4
SEX
Male	20.0	19.9	6.4	6.5	21.4	21.3	28.5	27.3	20.3	20.4
Female	14.3	13.7	10.6	9.2	14.7	14.2	25.8	24.5	13.0	12.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	17.4	17.1	8.0	7.7	18.3	17.9	27.7	26.4	17.0	16.7
AIAN	25.3	21.3	7.4	6.2	29.1	24.0	*	32.8	27.5	22.7
Asian	9.2	8.7	4.0	3.9	9.7	9.1	16.8	13.2	8.5	8.5
Black or African American	17.6	17.2	7.3	7.6	18.8	18.3	27.8	26.2	17.2	17.0
NHPI	*	12.1	2.1	1.7	*	12.8	*	*	*	11.3
White	17.8	17.8	8.4	8.1	18.6	18.5	28.6	27.8	17.3	17.4
Two or More Races	24.3	22.6	11.1	10.3	26.6	24.9	33.2	32.2	24.9	23.0
Hispanic or Latino	15.7	15.5	9.9	8.0	16.5	16.5	25.4	24.6	14.6	14.7
EDUCATION LEVEL
< High School	da	da	da	da	18.5	17.1	27.1	25.2	17.1	15.7
High School Graduate	da	da	da	da	19.0	18.7	27.1	25.4	17.4	17.3
Some College/Associate’s Degree	da	da	da	da	19.4	20.0	28.3	26.9	17.6	18.5
College Graduate	da	da	da	da	15.7	15.0	24.5	25.3	15.1	14.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	19.8	18.8	29.8	29.7	18.5	17.3
Part-Time	da	da	da	da	19.7	19.3	28.6^b	24.1	16.4	17.6
Unemployed	da	da	da	da	28.9	28.1	30.4	29.4	28.3	27.6
Other¹	da	da	da	da	13.7	14.3	19.9	20.1	13.1	13.7
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.11A – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	27,153	28,184	1,780	1,705	25,373	26,480	6,113	6,210	19,260	20,269
GEOGRAPHIC REGION
Northeast	5,099	4,967	285	216	4,814	4,751	1,145	1,084	3,670	3,666
Midwest	5,615	6,096	378	302	5,237	5,794	1,327	1,398	3,910	4,396
South	9,458	10,168	678	705	8,780	9,463	2,047	2,100	6,733	7,363
West	6,981	6,953	439	481	6,542	6,472	1,594	1,628	4,948	4,844
COUNTY TYPE
Large Metro	14,571	15,416	983	853	13,587	14,563	3,089	3,369	10,499	11,194
Small Metro	8,886	8,971	610	670	8,275	8,301	2,239	2,132	6,037	6,168
Nonmetro	3,697	3,798	186	182	3,510	3,616	785	709	2,725	2,907
Urbanized	1,553	1,587	70	65	1,484	1,522	396	392	1,088	1,130
Less Urbanized	1,914	2,034	93	106	1,821	1,928	353	297	1,468	1,630
Completely Rural	229	177	24	10	206	166	37	20	169	146
POVERTY LEVEL¹
Less Than 100%	6,234	6,687	357	375	5,877	6,312	1,423	1,432	4,455	4,880
100-199%	6,240	6,652	409	402	5,831	6,250	1,540	1,492	4,291	4,758
200% or More	14,669	14,833	1,014	928	13,655	13,905	3,141	3,274	10,515	10,631
HEALTH INSURANCE²
Private	13,115	13,644	934	842	12,181	12,801	3,199	3,239	8,982	9,562
Medicaid/CHIP	9,298	9,404	838	799	8,460	8,605	2,009	1,716	6,451	6,889
Other³	5,424	4,995	96	58	5,328	4,937	542	476	4,787	4,461
No Coverage	3,265	3,664	50^a	99	3,215	3,565	723^b	1,016	2,492	2,549
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Drug use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.11B – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	9.6	9.8	6.9	6.6	9.9	10.1	18.0	17.8	8.6	8.9
GEOGRAPHIC REGION
Northeast	10.4	10.0	7.0	5.3	10.7	10.4	19.9	18.4	9.4	9.2
Midwest	9.6	10.3	7.0	5.6	9.9	10.8	18.6	19.2	8.6	9.5
South	8.7	9.1	6.6	6.8	8.9	9.4	15.6	15.5	7.8	8.4
West	10.4	10.2	7.1	7.8	10.8	10.4	19.8	19.8	9.4	9.0
COUNTY TYPE
Large Metro	9.3	9.5	6.9	5.8	9.5	9.9	16.8	18.1	8.4	8.7
Small Metro	10.0	9.7	7.4	8.0	10.3	9.9	19.6	17.8	8.7	8.6
Nonmetro	9.8	11.0	5.5	6.3	10.3	11.4	18.4	16.3	9.1	10.7
Urbanized	10.2	11.1	5.7	5.7	10.6	11.6	21.0	18.0	9.0	10.3
Less Urbanized	9.9	11.6	5.0	7.0	10.4	12.1	16.9	15.7	9.5	11.6
Completely Rural	7.4	6.3	7.7	4.4	7.3	6.5	12.7	7.2	6.7	6.4
POVERTY LEVEL¹
Less Than 100%	13.8	14.4	6.2	6.8	14.9	15.4	16.9	17.1	14.4	15.0
100-199%	11.5	12.0	7.6	7.5	11.9	12.4	19.6	17.6	10.4	11.4
200% or More	8.0	8.0	6.8	6.1	8.1	8.1	17.7	18.3	6.9	7.0
HEALTH INSURANCE²
Private	7.7	7.8	6.7	5.8	7.8	7.9	16.8	16.4	6.5	6.8
Medicaid/CHIP	15.3	15.9	7.7	7.6	17.0	17.7	21.1	19.1	16.0	17.4
Other³	6.9	6.3	6.9	4.2	6.9	6.3	19.2	17.0	6.4	5.9
No Coverage	13.7	14.5	4.0^a	8.2	14.3	14.9	16.1^a	20.2	13.8	13.4
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Drug use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.12A – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)	Aged 12-20¹ (2023)	Aged 12-20¹ (2024)	Aged 21+¹ (2023)	Aged 21+¹ (2024)
TOTAL	28,859	27,913	757	775	28,103	27,138	5,123	5,029	22,980	22,108	2,109	1,998	26,750	25,915
GEOGRAPHIC REGION
Northeast	5,159	4,732	115	127	5,044	4,605	948^a	758	4,096	3,847	348	285	4,811	4,448
Midwest	6,091	6,241	187	150	5,904	6,090	1,130	1,097	4,774	4,993	473	429	5,618	5,812
South	10,820	9,971	264	303	10,556	9,668	1,871	1,974	8,685^a	7,694	767	803	10,053	9,169
West	6,789	6,968	191	195	6,598	6,774	1,173	1,200	5,425	5,573	521	482	6,269	6,486
COUNTY TYPE
Large Metro	16,422	16,498	349	416	16,073	16,082	2,803	2,680	13,270	13,402	1,057	969	15,365	15,530
Small Metro	9,418	8,556	301	257	9,117	8,299	1,751	1,719	7,366	6,581	773	695	8,645	7,861
Nonmetro	3,020	2,859	107	102	2,913	2,757	569	631	2,344	2,125	279	335	2,741	2,524
Urbanized	1,281	1,257	44	26	1,237	1,231	255	344	982	887	123	148	1,158	1,109
Less Urbanized	1,532	1,407	56	71	1,476	1,336	278	257	1,198	1,079	141	171	1,391	1,235
Completely Rural	207	195	7	5	200	190	36	31	164	159	15	16	193	179
POVERTY LEVEL²
Less Than 100%	4,302	4,499	148	133	4,154	4,367	1,247	1,150	2,907	3,217	567	503	3,735	3,997
100-199%	4,802	4,597	144	156	4,658	4,441	1,165	1,207	3,493	3,234	361	430	4,442	4,167
200% or More	19,749	18,790	464	486	19,285	18,303	2,705	2,646	16,580	15,657	1,176	1,047	18,574	17,743
HEALTH INSURANCE³
Private	17,819	17,371	417	456	17,402	16,915	3,164	2,980	14,237	13,935	1,243	1,129	16,576	16,242
Medicaid/CHIP	5,836	5,415	309	310	5,526	5,105	1,196	1,062	4,331	4,043	678	610	5,158	4,805
Other⁴	5,212	4,748	42	29	5,170	4,719	421	366	4,749	4,353	179	124	5,033	4,624
No Coverage	3,095	3,229	31	34	3,064	3,194	636	773	2,428	2,421	144	230	2,951	2,999
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ The aged 12-20 and aged 21+ columns are included because they are the underage and legal age groups for alcohol. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.12B – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)	Aged 12-20¹ (2023)	Aged 12-20¹ (2024)	Aged 21+¹ (2023)	Aged 21+¹ (2024)
TOTAL	10.2	9.7	2.9	3.0	10.9	10.3	15.1	14.4	10.3	9.7	5.5	5.2	10.9	10.4
GEOGRAPHIC REGION
Northeast	10.5	9.5	2.8	3.1	11.2	10.1	16.5^a	12.8	10.5	9.7	5.8	4.7	11.2	10.2
Midwest	10.5	10.6	3.4	2.8	11.2	11.4	15.8	15.1	10.5	10.8	5.8	5.3	11.2	11.4
South	9.9^a	8.9	2.6	2.9	10.7^a	9.6	14.3	14.6	10.1^a	8.8	5.2	5.3	10.6^a	9.5
West	10.1	10.2	3.1	3.2	10.8	10.9	14.6	14.6	10.3	10.4	5.7	5.3	10.8	11.0
COUNTY TYPE
Large Metro	10.5	10.2	2.4	2.8	11.3	11.0	15.3	14.4	10.7	10.5	5.1	4.6	11.3	11.1
Small Metro	10.6^b	9.3	3.6	3.1	11.3^b	9.9	15.3	14.4	10.6^a	9.2	6.2	5.5	11.3^a	9.9
Nonmetro	8.0	8.3	3.1	3.5	8.5	8.7	13.4	14.5	7.8	7.8	5.6	7.1	8.4	8.5
Urbanized	8.4	8.8	3.6	2.3	8.9	9.4	13.5	15.8	8.1	8.1	6.4	7.2	8.7	9.1
Less Urbanized	7.9	8.1	3.0	4.6	8.4	8.4	13.3	13.5	7.8	7.7	5.3	7.5	8.3	8.1
Completely Rural	6.7	7.0	2.2	2.1	7.1	7.4	12.2	11.0	6.6	7.0	3.8	4.3	7.1	7.4
POVERTY LEVEL²
Less Than 100%	9.5	9.7	2.6	2.4	10.5	10.7	14.8	13.7	9.4	9.9	6.3	5.6	10.3	10.6
100-199%	8.8	8.3	2.7	2.9	9.5	8.8	14.8	14.2	8.5	7.7	4.5	5.2	9.6	8.8
200% or More	10.7	10.1	3.1	3.2	11.4	10.7	15.3	14.8	11.0	10.2	5.6	4.9	11.4	10.8
HEALTH INSURANCE³
Private	10.4	9.9	3.0	3.1	11.1	10.5	16.6	15.1	10.3	9.9	6.1	5.3	11.0	10.5
Medicaid/CHIP	9.6	9.2	2.8	3.0	11.1	10.5	12.5	11.8	10.7	10.2	4.5	4.2	11.3	10.8
Other⁴	6.6	6.0	3.0	2.1	6.7	6.1	14.9	13.1	6.4	5.8	7.4	5.2	6.6	6.0
No Coverage	13.0	12.8	2.5	2.8	13.6	13.3	14.2	15.3	13.5	12.8	5.5	7.9	14.0	13.4
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ The aged 12-20 and aged 21+ columns are included because they are the underage and legal age groups for alcohol. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.13A – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	48,464	48,351	2,192	2,024	46,272	46,327	9,228	9,056	37,044	37,271
GEOGRAPHIC REGION
Northeast	8,956	8,428	347	278	8,609	8,149	1,713	1,509	6,895	6,641
Midwest	10,106	10,475	476^a	360	9,630	10,115	2,001	2,012	7,629	8,103
South	17,702	17,371	848	812	16,854	16,559	3,276	3,254	13,578	13,306
West	11,699	12,077	520	573	11,179	11,504	2,238	2,282	8,941	9,222
COUNTY TYPE
Large Metro	26,923	27,485	1,175	1,062	25,748	26,423	4,789	4,827	20,959	21,596
Small Metro	15,660	15,080	777	738	14,883	14,342	3,325	3,160	11,558	11,182
Nonmetro	5,881	5,786	240	224	5,641	5,562	1,114	1,069	4,526	4,493
Urbanized	2,459	2,468	84	83	2,375	2,385	542	578	1,834	1,807
Less Urbanized	3,012	2,982	128	128	2,884	2,854	511	447	2,374	2,407
Completely Rural	409	336	28	13	381	323	62	44	319	278
POVERTY LEVEL¹
Less Than 100%	9,009	9,468	442	430	8,566	9,038	2,214	2,073	6,352	6,965
100-199%	9,307	9,528	489	467	8,818	9,061	2,238	2,184	6,581	6,877
200% or More	30,138	29,320	1,261	1,127	28,877	28,193	4,766	4,764	24,111	23,429
HEALTH INSURANCE²
Private	27,196	27,199	1,146	1,059	26,051	26,139	5,234	5,061	20,816	21,078
Medicaid/CHIP	12,821	12,545	1,001	899	11,819	11,646	2,675^a	2,246	9,144	9,400
Other³	9,405	8,850	122	78	9,283	8,773	780	681	8,503	8,092
No Coverage	5,267	5,596	72	123	5,195	5,473	1,091^b	1,387	4,104	4,086
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.13B – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	17.1	16.8	8.5	7.8	18.0	17.7	27.1	25.9	16.6	16.4
GEOGRAPHIC REGION
Northeast	18.3	16.9	8.5	6.8	19.2	17.8	29.8^a	25.5	17.6	16.7
Midwest	17.4	17.8	8.8^a	6.7	18.2	18.9	28.0	27.6	16.7	17.5
South	16.2	15.6	8.3	7.9	17.0	16.4	25.0	24.1	15.8	15.2
West	17.5	17.7	8.5	9.3	18.4	18.6	27.9	27.7	16.9	17.2
COUNTY TYPE
Large Metro	17.2	17.0	8.2	7.2	18.1	18.0	26.1	25.9	16.9	16.8
Small Metro	17.6	16.4	9.4	8.8	18.4	17.1	29.1	26.4	16.7	15.6
Nonmetro	15.6	16.8	7.1	7.7	16.5	17.6	26.2	24.5	15.1	16.5
Urbanized	16.2	17.3	6.9	7.3	17.0	18.2	28.8	26.5	15.2	16.5
Less Urbanized	15.6	17.1	6.9	8.4	16.5	17.9	24.5	23.5	15.4	17.1
Completely Rural	13.2	12.0	9.2	5.5	13.6	12.6	21.2	15.9	12.7	12.2
POVERTY LEVEL¹
Less Than 100%	19.9	20.4	7.7	7.8	21.7	22.1	26.3	24.8	20.5	21.4
100-199%	17.1	17.1	9.1	8.8	18.0	18.0	28.4	25.7	16.0	16.4
200% or More	16.4	15.8	8.5	7.5	17.1	16.5	26.9	26.6	15.9	15.3
HEALTH INSURANCE²
Private	15.9	15.5	8.2	7.2	16.6	16.2	27.4	25.7	15.1	14.9
Medicaid/CHIP	21.1	21.3	9.2	8.6	23.7	24.0	28.1^a	25.0	22.7	23.8
Other³	12.0	11.2	8.8	5.6	12.0	11.3	27.7	24.4	11.4	10.8
No Coverage	22.1	22.2	5.7^a	10.2	23.1	22.8	24.3	27.5	22.7	21.6
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.14A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Treatment for Drugs (2023)	Treatment for Drugs (2024)	Treatment for Alcohol (2023)	Treatment for Alcohol (2024)	Treatment for Both Drugs and Alcohol (2023)	Treatment for Both Drugs and Alcohol (2024)	Treatment for Substance Unspecified¹ (2023)	Treatment for Substance Unspecified¹ (2024)	Treatment for Substance Use¹ (2023)	Treatment for Substance Use¹ (2024)
TOTAL	--	5,533	--	4,112	--	1,676	--	2,204	--	10,174
12-20²	--	627	--	298	--	149	--	274	--	1,050
21 or Older²	--	4,906	--	3,814	--	1,526	--	1,930	--	9,124
12-17	--	466	--	171	--	101	--	196	--	732
12-13	--	83	--	10	--	1	--	59	--	150
14-15	--	149	--	70	--	31	--	69	--	257
16-17	--	234	--	91	--	69	--	68	--	325
18 or Older	--	5,067	--	3,941	--	1,575	--	2,008	--	9,442
18-25	--	604	--	428	--	203	--	231	--	1,059
18-20	--	161	--	127	--	49	--	78	--	318
21-25	--	443	--	301	--	155	--	153	--	741
26 or Older	--	4,463	--	3,513	--	1,371	--	1,778	--	8,383
26-49	--	2,863	--	2,121	--	893	--	836	--	4,927
26-29	--	400	--	277	--	92	--	96	--	681
30-34	--	638	--	455	--	191	--	191	--	1,093
35-39	--	703	--	447	--	213	--	203	--	1,140
40-44	--	592	--	480	--	163	--	185	--	1,094
45-49	--	530	--	461	--	233	--	160	--	918
50 or Older	--	1,601	--	1,393	--	479	--	942	--	3,456
50-54	--	301	--	239	--	144	--	324	--	720
55-59	--	419	--	427	--	123	--	165	--	888
60-64	--	409	--	311	--	99	--	252	--	873
65 or Older	--	472	--	416	--	113	--	201	--	976
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received. ² The 12-20 and 21 or older rows are included because they are the underage and legal age groups for alcohol. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.14B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Treatment for Drugs (2023)	Treatment for Drugs (2024)	Treatment for Alcohol (2023)	Treatment for Alcohol (2024)	Treatment for Both Drugs and Alcohol (2023)	Treatment for Both Drugs and Alcohol (2024)	Treatment for Substance Unspecified¹ (2023)	Treatment for Substance Unspecified¹ (2024)	Treatment for Substance Use¹ (2023)	Treatment for Substance Use¹ (2024)
TOTAL	--	1.9	--	1.4	--	0.6	--	0.8	--	3.5
12-20²	--	1.6	--	0.8	--	0.4	--	0.7	--	2.7
21 or Older²	--	2.0	--	1.5	--	0.6	--	0.8	--	3.7
12-17	--	1.8	--	0.7	--	0.4	--	0.8	--	2.8
12-13	--	1.0	--	0.1	--	<0.1	--	0.7	--	1.9
14-15	--	1.7	--	0.8	--	0.3	--	0.8	--	2.9
16-17	--	2.6	--	1.0	--	0.8	--	0.8	--	3.6
18 or Older	--	1.9	--	1.5	--	0.6	--	0.8	--	3.6
18-25	--	1.7	--	1.2	--	0.6	--	0.7	--	3.0
18-20	--	1.3	--	1.0	--	0.4	--	0.6	--	2.5
21-25	--	2.0	--	1.3	--	0.7	--	0.7	--	3.3
26 or Older	--	2.0	--	1.5	--	0.6	--	0.8	--	3.7
26-49	--	2.7	--	2.0	--	0.8	--	0.8	--	4.7
26-29	--	2.3	--	1.6	--	0.5	--	0.6	--	3.9
30-34	--	2.7	--	1.9	--	0.8	--	0.8	--	4.7
35-39	--	3.0	--	1.9	--	0.9	--	0.9	--	4.9
40-44	--	2.6	--	2.1	--	0.7	--	0.8	--	4.9
45-49	--	2.8	--	2.4	--	1.2	--	0.8	--	4.8
50 or Older	--	1.3	--	1.1	--	0.4	--	0.8	--	2.8
50-54	--	1.5	--	1.2	--	0.7	--	1.6	--	3.7
55-59	--	2.2	--	2.2	--	0.6	--	0.8	--	4.6
60-64	--	1.8	--	1.4	--	0.4	--	1.1	--	3.9
65 or Older	--	0.8	--	0.7	--	0.2	--	0.3	--	1.6
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received. ² The 12-20 and 21 or older rows are included because they are the underage and legal age groups for alcohol. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.15A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	10,174	--	732	--	9,442	--	1,059	--	8,383
SEX
Male	--	5,462	--	319	--	5,143	--	494	--	4,649
Female	--	4,712	--	413	--	4,299	--	565	--	3,734
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	8,563	--	545	--	8,018	--	787	--	7,231
AIAN	--	153	--	17	--	136	--	9	--	127
Asian	--	176	--	19	--	156	--	15	--	141
Black or African American	--	1,414	--	134	--	1,280	--	170	--	1,110
NHPI	--	32	--	2	--	30	--	1	--	29
White	--	6,512	--	336	--	6,177	--	530	--	5,647
Two or More Races	--	276	--	36	--	239	--	62	--	178
Hispanic or Latino	--	1,611	--	187	--	1,424	--	271	--	1,152
EDUCATION LEVEL
< High School	da	da	da	da	--	1,291	--	159	--	1,133
High School Graduate	da	da	da	da	--	3,161	--	424	--	2,737
Some College/Associate’s Degree	da	da	da	da	--	3,041	--	358	--	2,683
College Graduate	da	da	da	da	--	1,949	--	118	--	1,831
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	3,590	--	348	--	3,241
Part-Time	da	da	da	da	--	1,233	--	243	--	990
Unemployed	da	da	da	da	--	839	--	149	--	690
Other¹	da	da	da	da	--	3,780	--	318	--	3,462
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.15B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	3.5	--	2.8	--	3.6	--	3.0	--	3.7
SEX
Male	--	3.9	--	2.4	--	4.0	--	2.8	--	4.2
Female	--	3.2	--	3.3	--	3.2	--	3.2	--	3.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	3.7	--	2.9	--	3.7	--	3.0	--	3.8
AIAN	--	11.2	--	8.2	--	11.8	--	5.6	--	12.7
Asian	--	0.9	--	1.3	--	0.9	--	0.6	--	1.0
Black or African American	--	4.0	--	3.8	--	4.0	--	3.7	--	4.1
NHPI	--	2.6	--	2.2	--	2.6	--	1.0	--	2.8
White	--	3.8	--	2.7	--	3.9	--	3.0	--	4.0
Two or More Races	--	4.3	--	3.5	--	4.4	--	5.4	--	4.1
Hispanic or Latino	--	2.9	--	2.7	--	3.0	--	3.1	--	3.0
EDUCATION LEVEL
< High School	da	da	da	da	--	5.4	--	4.5	--	5.5
High School Graduate	da	da	da	da	--	4.5	--	3.5	--	4.7
Some College/Associate’s Degree	da	da	da	da	--	3.9	--	2.7	--	4.2
College Graduate	da	da	da	da	--	2.2	--	2.0	--	2.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	3.0	--	2.5	--	3.0
Part-Time	da	da	da	da	--	3.8	--	2.8	--	4.2
Unemployed	da	da	da	da	--	6.5	--	4.1	--	7.5
Other¹	da	da	da	da	--	3.9	--	3.8	--	4.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.16A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Treatment for Drugs (2023)	Treatment for Drugs (2024)	Treatment for Alcohol (2023)	Treatment for Alcohol (2024)	Treatment for Both Drugs and Alcohol (2023)	Treatment for Both Drugs and Alcohol (2024)	Treatment for Substance Unspecified¹ (2023)	Treatment for Substance Unspecified¹ (2024)	Treatment for Substance Use¹ (2023)	Treatment for Substance Use¹ (2024)
TOTAL	--	5,533	--	4,112	--	1,676	--	2,204	--	10,174
SEX
Male	--	3,042	--	2,500	--	1,061	--	981	--	5,462
Female	--	2,491	--	1,612	--	614	--	1,223	--	4,712
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	4,698	--	3,474	--	1,434	--	1,825	--	8,563
AIAN	--	68	--	84	--	26	--	27	--	153
Asian	--	72	--	90	--	34	--	46	--	176
Black or African American	--	680	--	611	--	262	--	386	--	1,414
NHPI	--	16	--	19	--	*	--	2	--	32
White	--	3,687	--	2,589	--	1,063	--	1,299	--	6,512
Two or More Races	--	175	--	81	--	45	--	65	--	276
Hispanic or Latino	--	835	--	639	--	242	--	379	--	1,611
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.16B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Treatment for Drugs (2023)	Treatment for Drugs (2024)	Treatment for Alcohol (2023)	Treatment for Alcohol (2024)	Treatment for Both Drugs and Alcohol (2023)	Treatment for Both Drugs and Alcohol (2024)	Treatment for Substance Unspecified¹ (2023)	Treatment for Substance Unspecified¹ (2024)	Treatment for Substance Use¹ (2023)	Treatment for Substance Use¹ (2024)
TOTAL	--	1.9	--	1.4	--	0.6	--	0.8	--	3.5
SEX
Male	--	2.2	--	1.8	--	0.8	--	0.7	--	3.9
Female	--	1.7	--	1.1	--	0.4	--	0.8	--	3.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	2.0	--	1.5	--	0.6	--	0.8	--	3.7
AIAN	--	5.0	--	6.2	--	1.9	--	2.0	--	11.2
Asian	--	0.4	--	0.5	--	0.2	--	0.2	--	0.9
Black or African American	--	1.9	--	1.7	--	0.7	--	1.1	--	4.0
NHPI	--	1.3	--	1.5	--	*	--	0.1	--	2.6
White	--	2.2	--	1.5	--	0.6	--	0.8	--	3.8
Two or More Races	--	2.7	--	1.2	--	0.7	--	1.0	--	4.3
Hispanic or Latino	--	1.5	--	1.2	--	0.4	--	0.7	--	2.9
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.17A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older with Past Year Substance Use Disorder; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	5,926	--	330	--	5,596	--	766	--	4,830
SEX
Male	--	3,403	--	107	--	3,296	--	388	--	2,909
Female	--	2,523	--	223	--	2,300	--	379	--	1,921
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	5,038	--	254	--	4,784	--	588	--	4,196
AIAN	--	48	--	*	--	43	--	*	--	*
Asian	--	84	--	*	--	71	--	7	--	65
Black or African American	--	731	--	49	--	682	--	115	--	567
NHPI	--	*	--	*	--	*	--	*	--	*
White	--	3,981	--	177	--	3,804	--	410	--	3,394
Two or More Races	--	181	--	*	--	170	--	48	--	122
Hispanic or Latino	--	888	--	76	--	812	--	178	--	634
EDUCATION LEVEL
< High School	da	da	da	da	--	781	--	109	--	672
High School Graduate	da	da	da	da	--	1,857	--	305	--	1,552
Some College/Associate’s Degree	da	da	da	da	--	1,766	--	261	--	1,505
College Graduate	da	da	da	da	--	1,192	--	91	--	1,101
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	2,112	--	266	--	1,847
Part-Time	da	da	da	da	--	764	--	165	--	598
Unemployed	da	da	da	da	--	523	--	114	--	410
Other¹	da	da	da	da	--	2,197	--	222	--	1,975
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.17B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older with Past Year Substance Use Disorder; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	12.3	--	16.3	--	12.1	--	8.5	--	13.0
SEX
Male	--	12.1	--	12.5	--	12.1	--	8.1	--	13.0
Female	--	12.5	--	19.1	--	12.1	--	8.9	--	13.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	12.6	--	17.3	--	12.4	--	8.5	--	13.3
AIAN	--	16.4	--	*	--	15.6	--	*	--	*
Asian	--	5.2	--	*	--	4.6	--	2.0	--	5.2
Black or African American	--	12.0	--	18.0	--	11.7	--	9.6	--	12.3
NHPI	--	*	--	*	--	*	--	*	--	*
White	--	13.1	--	17.4	--	13.0	--	8.3	--	13.9
Two or More Races	--	12.3	--	*	--	12.5	--	13.1	--	12.3
Hispanic or Latino	--	10.5	--	13.7	--	10.3	--	8.3	--	11.1
EDUCATION LEVEL
< High School	da	da	da	da	--	19.0	--	12.2	--	20.9
High School Graduate	da	da	da	da	--	14.1	--	9.9	--	15.4
Some College/Associate’s Degree	da	da	da	da	--	11.4	--	7.3	--	12.6
College Graduate	da	da	da	da	--	8.8	--	6.0	--	9.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	9.3	--	6.4	--	9.9
Part-Time	da	da	da	da	--	12.2	--	7.8	--	14.4
Unemployed	da	da	da	da	--	14.4	--	10.5	--	16.1
Other¹	da	da	da	da	--	16.0	--	13.1	--	16.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.18A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Treatment for Drugs (2023)	Treatment for Drugs (2024)	Treatment for Alcohol (2023)	Treatment for Alcohol (2024)	Treatment for Both Drugs and Alcohol (2023)	Treatment for Both Drugs and Alcohol (2024)	Treatment for Substance Unspecified¹ (2023)	Treatment for Substance Unspecified¹ (2024)	Treatment for Substance Use¹ (2023)	Treatment for Substance Use¹ (2024)
TOTAL	--	5,533	--	4,112	--	1,676	--	2,204	--	10,174
GEOGRAPHIC REGION
Northeast	--	1,149	--	610	--	300	--	260	--	1,718
Midwest	--	1,151	--	944	--	344	--	524	--	2,275
South	--	1,998	--	1,547	--	627	--	983	--	3,902
West	--	1,235	--	1,011	--	404	--	437	--	2,278
COUNTY TYPE
Large Metro	--	2,896	--	2,426	--	923	--	1,090	--	5,489
Small Metro	--	1,772	--	1,232	--	510	--	797	--	3,291
Nonmetro	--	865	--	454	--	243	--	317	--	1,394
Urbanized	--	254	--	133	--	70	--	185	--	501
Less Urbanized	--	576	--	288	--	168	--	119	--	814
Completely Rural	--	36	--	33	--	5	--	14	--	79
POVERTY LEVEL²
Less Than 100%	--	2,014	--	1,039	--	545	--	622	--	3,130
100-199%	--	1,241	--	784	--	355	--	679	--	2,350
200% or More	--	2,277	--	2,289	--	776	--	902	--	4,692
HEALTH INSURANCE³
Private	--	2,249	--	2,100	--	713	--	1,047	--	4,683
Medicaid/CHIP	--	2,699	--	1,331	--	687	--	1,025	--	4,367
Other⁴	--	1,145	--	1,061	--	423	--	611	--	2,393
No Coverage	--	438	--	419	--	202	--	104	--	759
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.18B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Treatment for Drugs (2023)	Treatment for Drugs (2024)	Treatment for Alcohol (2023)	Treatment for Alcohol (2024)	Treatment for Both Drugs and Alcohol (2023)	Treatment for Both Drugs and Alcohol (2024)	Treatment for Substance Unspecified¹ (2023)	Treatment for Substance Unspecified¹ (2024)	Treatment for Substance Use¹ (2023)	Treatment for Substance Use¹ (2024)
TOTAL	--	1.9	--	1.4	--	0.6	--	0.8	--	3.5
GEOGRAPHIC REGION
Northeast	--	2.3	--	1.2	--	0.6	--	0.5	--	3.5
Midwest	--	2.0	--	1.6	--	0.6	--	0.9	--	3.9
South	--	1.8	--	1.4	--	0.6	--	0.9	--	3.5
West	--	1.8	--	1.5	--	0.6	--	0.6	--	3.3
COUNTY TYPE
Large Metro	--	1.8	--	1.5	--	0.6	--	0.7	--	3.4
Small Metro	--	1.9	--	1.3	--	0.6	--	0.9	--	3.6
Nonmetro	--	2.5	--	1.3	--	0.7	--	0.9	--	4.0
Urbanized	--	1.8	--	0.9	--	0.5	--	1.3	--	3.5
Less Urbanized	--	3.3	--	1.6	--	1.0	--	0.7	--	4.7
Completely Rural	--	1.3	--	1.2	--	0.2	--	0.5	--	2.8
POVERTY LEVEL²
Less Than 100%	--	4.3	--	2.2	--	1.2	--	1.3	--	6.7
100-199%	--	2.2	--	1.4	--	0.6	--	1.2	--	4.2
200% or More	--	1.2	--	1.2	--	0.4	--	0.5	--	2.5
HEALTH INSURANCE³
Private	--	1.3	--	1.2	--	0.4	--	0.6	--	2.7
Medicaid/CHIP	--	4.6	--	2.3	--	1.2	--	1.7	--	7.4
Other⁴	--	1.4	--	1.3	--	0.5	--	0.8	--	3.0
No Coverage	--	1.7	--	1.7	--	0.8	--	0.4	--	3.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.19A – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Inpatient in Past Year; by Age Group, Numbers in Thousands, 2023 and 2024
Substance for Which Treatment Was Received¹	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE TREATMENT²	--	2,603	--	273	--	2,330	--	354	--	1,976
DRUGS	--	1,439	--	156	--	1,282	--	212	--	1,071
Marijuana	--	466	--	71	--	395	--	125	--	271
Cocaine	--	250	--	*	--	242	--	27	--	215
Heroin	--	273	--	1	--	272	--	27	--	245
Hallucinogens	--	135	--	15	--	120	--	52	--	69
Inhalants	--	76	--	*	--	35	--	10	--	25
Methamphetamine	--	441	--	<1	--	440	--	52	--	388
Prescription Psychotherapeutics	--	581	--	52	--	530	--	71	--	459
Pain Relievers	--	417	--	37	--	380	--	55	--	325
Stimulants	--	106	--	13	--	93	--	26	--	67
Tranquilizers or Sedatives	--	287	--	11	--	275	--	29	--	247
Tranquilizers	--	278	--	*	--	272	--	28	--	244
Sedatives	--	93	--	6	--	88	--	12	--	76
Opioids	--	631	--	38	--	594	--	71	--	522
Central Nervous System Stimulants	--	682	--	21	--	661	--	82	--	579
ALCOHOL	--	902	--	63	--	839	--	118	--	721
BOTH DRUGS AND ALCOHOL	--	361	--	35	--	326	--	61	--	265
*SUBSTANCE UNSPECIFIED²*	--	623	--	89	--	534	--	85	--	449
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive. ² Includes data from respondents who reported that they received inpatient substance use treatment but did not report the substance(s) for which they received treatment. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.19B – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Inpatient in Past Year; by Age Group, Percentages, 2023 and 2024
Substance for Which Treatment Was Received¹	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE TREATMENT²	--	100.0	--	100.0	--	100.0	--	100.0	--	100.0
DRUGS	--	55.3	--	57.2	--	55.0	--	59.8	--	54.2
Marijuana	--	17.9	--	26.1	--	17.0	--	35.2	--	13.7
Cocaine	--	9.6	--	*	--	10.4	--	7.8	--	10.9
Heroin	--	10.5	--	0.3	--	11.7	--	7.7	--	12.4
Hallucinogens	--	5.2	--	5.4	--	5.2	--	14.7	--	3.5
Inhalants	--	2.9	--	*	--	1.5	--	2.8	--	1.3
Methamphetamine	--	16.9	--	0.1	--	18.9	--	14.8	--	19.6
Prescription Psychotherapeutics	--	22.3	--	18.9	--	22.7	--	20.0	--	23.2
Pain Relievers	--	16.0	--	13.6	--	16.3	--	15.6	--	16.4
Stimulants	--	4.1	--	4.9	--	4.0	--	7.4	--	3.4
Tranquilizers or Sedatives	--	11.0	--	4.1	--	11.8	--	8.1	--	12.5
Tranquilizers	--	10.7	--	*	--	11.7	--	7.9	--	12.4
Sedatives	--	3.6	--	2.2	--	3.8	--	3.4	--	3.8
Opioids	--	24.2	--	13.8	--	25.5	--	20.2	--	26.4
Central Nervous System Stimulants	--	26.2	--	7.7	--	28.4	--	23.3	--	29.3
ALCOHOL	--	34.7	--	23.2	--	36.0	--	33.3	--	36.5
BOTH DRUGS AND ALCOHOL	--	13.9	--	12.9	--	14.0	--	17.1	--	13.4
*SUBSTANCE UNSPECIFIED²*	--	23.9	--	32.5	--	22.9	--	24.0	--	22.7
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive. ² Includes data from respondents who reported that they received inpatient substance use treatment but did not report the substance(s) for which they received treatment. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.20A – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Outpatient in Past Year; by Age Group, Numbers in Thousands, 2023 and 2024
Substance for Which Treatment Was Received¹	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE TREATMENT²	--	7,096	--	456	--	6,640	--	740	--	5,900
DRUGS	--	3,378	--	276	--	3,102	--	410	--	2,691
Marijuana	--	938	--	113	--	825	--	216	--	609
Cocaine	--	407	--	*	--	400	--	22	--	378
Heroin	--	606	--	*	--	602	--	30	--	572
Hallucinogens	--	186	--	30	--	156	--	49	--	107
Inhalants	--	139	--	48	--	91	--	9	--	82
Methamphetamine	--	753	--	*	--	753	--	63	--	690
Prescription Psychotherapeutics	--	1,853	--	133	--	1,720	--	143	--	1,578
Pain Relievers	--	1,489	--	93	--	1,395	--	87	--	1,308
Stimulants	--	249	--	24	--	225	--	42	--	183
Tranquilizers or Sedatives	--	526	--	29	--	497	--	59	--	439
Tranquilizers	--	454	--	19	--	435	--	49	--	386
Sedatives	--	148	--	10	--	138	--	19	--	118
Opioids	--	1,757	--	97	--	1,660	--	100	--	1,560
Central Nervous System Stimulants	--	1,172	--	31	--	1,141	--	110	--	1,031
ALCOHOL	--	2,220	--	85	--	2,135	--	207	--	1,928
BOTH DRUGS AND ALCOHOL	--	787	--	59	--	728	--	111	--	617
*SUBSTANCE UNSPECIFIED²*	--	2,285	--	154	--	2,132	--	234	--	1,898
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive. ² Includes data from respondents who reported that they received outpatient substance use treatment but did not report the substance(s) for which they received treatment. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.20B – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Outpatient in Past Year; by Age Group, Percentages, 2023 and 2024
Substance for Which Treatment Was Received¹	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE TREATMENT²	--	100.0	--	100.0	--	100.0	--	100.0	--	100.0
DRUGS	--	47.6	--	60.6	--	46.7	--	55.4	--	45.6
Marijuana	--	13.2	--	24.8	--	12.4	--	29.1	--	10.3
Cocaine	--	5.7	--	*	--	6.0	--	2.9	--	6.4
Heroin	--	8.5	--	*	--	9.1	--	4.1	--	9.7
Hallucinogens	--	2.6	--	6.5	--	2.4	--	6.6	--	1.8
Inhalants	--	2.0	--	10.5	--	1.4	--	1.2	--	1.4
Methamphetamine	--	10.6	--	*	--	11.3	--	8.5	--	11.7
Prescription Psychotherapeutics	--	26.1	--	29.1	--	25.9	--	19.3	--	26.7
Pain Relievers	--	21.0	--	20.5	--	21.0	--	11.8	--	22.2
Stimulants	--	3.5	--	5.2	--	3.4	--	5.6	--	3.1
Tranquilizers or Sedatives	--	7.4	--	6.4	--	7.5	--	7.9	--	7.4
Tranquilizers	--	6.4	--	4.2	--	6.5	--	6.6	--	6.5
Sedatives	--	2.1	--	2.3	--	2.1	--	2.6	--	2.0
Opioids	--	24.8	--	21.4	--	25.0	--	13.5	--	26.4
Central Nervous System Stimulants	--	16.5	--	6.8	--	17.2	--	14.8	--	17.5
ALCOHOL	--	31.3	--	18.6	--	32.2	--	28.0	--	32.7
BOTH DRUGS AND ALCOHOL	--	11.1	--	12.9	--	11.0	--	15.0	--	10.5
*SUBSTANCE UNSPECIFIED²*	--	32.2	--	33.7	--	32.1	--	31.6	--	32.2
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive. ² Includes data from respondents who reported that they received outpatient substance use treatment but did not report the substance(s) for which they received treatment. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.21A – Received Medications for Alcohol Use Disorder (MAUD) in Past Year: Among People Aged 12 or Older; Received MAUD in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Received MAUD (2023)	Received MAUD (2024)	Received MAUD among People with an Alcohol Use Disorder¹ (2023)	Received MAUD among People with an Alcohol Use Disorder¹ (2024)
TOTAL	1,146	1,309	554	697
AGE GROUP
12-17	13^a	51	2^a	33
18 or Older	1,133	1,258	552	665
18-25	88	123	58	86
26 or Older	1,044	1,136	494	579
SEX
Male	553	836	253	446
Female	593	473	301	251
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	996	1,100	497	588
AIAN	*	15	<1	4
Asian	9	4	*	*
Black or African American	94^a	218	29	62
NHPI	<1	1	*	*
White	866	849	452	506
Two or More Races	13	12	9	12
Hispanic or Latino	150	210	57	109
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.21B – Received Medications for Alcohol Use Disorder (MAUD) in Past Year: Among People Aged 12 or Older; Received MAUD in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Received MAUD (2023)	Received MAUD (2024)	Received MAUD among People with an Alcohol Use Disorder¹ (2023)	Received MAUD among People with an Alcohol Use Disorder¹ (2024)
TOTAL	0.4	0.5	1.9	2.5
AGE GROUP
12-17	0.1^a	0.2	0.3^a	4.2
18 or Older	0.4	0.5	2.0	2.4
18-25	0.3	0.4	1.1	1.7
26 or Older	0.5	0.5	2.2	2.6
SEX
Male	0.4	0.6	1.5	2.7
Female	0.4	0.3	2.5	2.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4	0.5	2.1	2.6
AIAN	*	1.1	<0.1	2.8
Asian	<0.1	<0.1	*	*
Black or African American	0.3^a	0.6	0.9	1.8
NHPI	<0.1	0.1	*	*
White	0.5	0.5	2.4	2.9
Two or More Races	0.2	0.2	1.1	1.8
Hispanic or Latino	0.3	0.4	1.2	2.2
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.22A – Received Medications for Opioid Use Disorder (MOUD) in Past Year: Among People Aged 12 or Older; Received MOUD in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Received MOUD (2023)	Received MOUD (2024)	Received MOUD among People with an Opioid Use Disorder¹ (2023)	Received MOUD among People with an Opioid Use Disorder¹ (2024)
TOTAL	2,296	2,155	1,013	818
AGE GROUP
12-17	37	36	*	15
18 or Older	2,258	2,119	1,002	803
18-25	99	68	40	42
26 or Older	2,159	2,051	962	760
SEX
Male	1,142	1,170	549	453
Female	1,153	984	464	365
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,977	1,952	864	707
AIAN	16	31	*	*
Asian	14	12	*	*
Black or African American	136	212	*	56
NHPI	2	*	*	*
White	1,781	1,644	754	622
Two or More Races	29	49	*	*
Hispanic or Latino	319	202	*	110
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder. Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.22B – Received Medications for Opioid Use Disorder (MOUD) in Past Year: Among People Aged 12 or Older; Received MOUD in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Received MOUD (2023)	Received MOUD (2024)	Received MOUD among People with an Opioid Use Disorder¹ (2023)	Received MOUD among People with an Opioid Use Disorder¹ (2024)
TOTAL	0.8	0.7	20.1	17.0
AGE GROUP
12-17	0.1	0.1	*	5.6
18 or Older	0.9	0.8	20.8	17.6
18-25	0.3	0.2	11.5	12.6
26 or Older	1.0	0.9	21.5	18.0
SEX
Male	0.8	0.8	22.4	19.3
Female	0.8	0.7	17.9	14.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.9	0.8	20.5	17.7
AIAN	1.2	2.3	*	*
Asian	0.1	0.1	*	*
Black or African American	0.4	0.6	*	12.3
NHPI	0.1	*	*	*
White	1.0	1.0	24.5	19.9
Two or More Races	0.5	0.7	*	*
Hispanic or Latino	0.6	0.4	*	13.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder. Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.23A – Received Medications for Alcohol Use Disorder (MAUD) in Past Year: Among People Aged 12 or Older; Received MAUD in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Received MAUD (2023)	Received MAUD (2024)	Received MAUD among People with an Alcohol Use Disorder¹ (2023)	Received MAUD among People with an Alcohol Use Disorder¹ (2024)
TOTAL	1,146	1,309	554	697
GEOGRAPHIC REGION
Northeast	197	211	81	166
Midwest	247	214	149	122
South	488	577	159	238
West	214	307	165	172
COUNTY TYPE
Large Metro	596	897	231^a	484
Small Metro	409	305	245	170
Nonmetro	141	106	78	43
Urbanized	46	28	15	14
Less Urbanized	84	75	53	25
Completely Rural	11	4	*	*
POVERTY LEVEL²
Less Than 100%	254	297	151	127
100-199%	159	245	74	133
200% or More	733	767	330	438
HEALTH INSURANCE³
Private	493	778	172^b	461
Medicaid/CHIP	492	329	300^b	122
Other⁴	251	386	93	164
No Coverage	79	92	41	61
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.23B – Received Medications for Alcohol Use Disorder (MAUD) in Past Year: Among People Aged 12 or Older; Received MAUD in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Received MAUD (2023)	Received MAUD (2024)	Received MAUD among People with an Alcohol Use Disorder¹ (2023)	Received MAUD among People with an Alcohol Use Disorder¹ (2024)
TOTAL	0.4	0.5	1.9	2.5
GEOGRAPHIC REGION
Northeast	0.4	0.4	1.6	3.5
Midwest	0.4	0.4	2.4	1.9
South	0.4	0.5	1.5	2.4
West	0.3	0.5	2.4	2.5
COUNTY TYPE
Large Metro	0.4	0.6	1.4^a	2.9
Small Metro	0.5	0.3	2.6	2.0
Nonmetro	0.4	0.3	2.6	1.5
Urbanized	0.3	0.2	1.2	1.1
Less Urbanized	0.4	0.4	3.4	1.8
Completely Rural	0.3	0.1	*	*
POVERTY LEVEL²
Less Than 100%	0.6	0.6	3.5	2.8
100-199%	0.3	0.4	1.5	2.9
200% or More	0.4	0.4	1.7	2.3
HEALTH INSURANCE³
Private	0.3	0.4	1.0^b	2.7
Medicaid/CHIP	0.8	0.6	5.1^a	2.3
Other⁴	0.3	0.5	1.8	3.5
No Coverage	0.3	0.4	1.3	1.9
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.24A – Received Medications for Opioid Use Disorder (MOUD) in Past Year: Among People Aged 12 or Older; Received MOUD in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Received MOUD (2023)	Received MOUD (2024)	Received MOUD among People with an Opioid Use Disorder¹ (2023)	Received MOUD among People with an Opioid Use Disorder¹ (2024)
TOTAL	2,296	2,155	1,013	818
GEOGRAPHIC REGION
Northeast	513	494	184	204
Midwest	494	385	182	183
South	784	823	356	281
West	505	453	*	150
COUNTY TYPE
Large Metro	993	1,017	560	348
Small Metro	796	854	255	331
Nonmetro	508^a	283	198	139
Urbanized	220^a	86	66	24
Less Urbanized	268	183	*	*
Completely Rural	20	14	*	*
POVERTY LEVEL²
Less Than 100%	796	728	382	322
100-199%	519	472	253	181
200% or More	980	955	378	315
HEALTH INSURANCE³
Private	788	863	326	277
Medicaid/CHIP	1,225	1,123	528	497
Other⁴	476	389	236	100
No Coverage	172	118	*	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder. Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.24B – Received Medications for Opioid Use Disorder (MOUD) in Past Year: Among People Aged 12 or Older; Received MOUD in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Received MOUD (2023)	Received MOUD (2024)	Received MOUD among People with an Opioid Use Disorder¹ (2023)	Received MOUD among People with an Opioid Use Disorder¹ (2024)
TOTAL	0.8	0.7	20.1	17.0
GEOGRAPHIC REGION
Northeast	1.0	1.0	23.8	25.5
Midwest	0.8	0.7	20.1	18.9
South	0.7	0.7	16.0	15.1
West	0.8	0.7	*	12.5
COUNTY TYPE
Large Metro	0.6	0.6	22.6	14.5
Small Metro	0.9	0.9	15.6	21.6
Nonmetro	1.3	0.8	21.3	15.5
Urbanized	1.4^a	0.6	15.0	7.5
Less Urbanized	1.4	1.0	*	*
Completely Rural	0.7	0.5	*	*
POVERTY LEVEL²
Less Than 100%	1.8	1.6	23.2	21.1
100-199%	1.0	0.8	23.2	14.4
200% or More	0.5	0.5	16.4	15.4
HEALTH INSURANCE³
Private	0.5	0.5	16.5	14.6
Medicaid/CHIP	2.0	1.9	25.6	24.2
Other⁴	0.6	0.5	11.2	5.4
No Coverage	0.7	0.5	*	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Opioid use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder. Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.25A – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2023)	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2024)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2023)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2024)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2023)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2024)
TOTAL	1,650	1,490	1,241	1,134	3,007	2,628
AGE GROUP
12-17	85	65	22	32	102	77
18 or Older	1,566	1,425	1,219	1,101	2,905	2,551
18-25	238	213	188	127	409	323
26 or Older	1,327	1,213	1,031	974	2,495	2,227
SEX
Male	821	865	760	622	1,590	1,456
Female	829	625	481	512	1,416	1,172
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,322	1,292	1,010	960	2,457	2,251
AIAN	15	16	2	5	16	18
Asian	26	22	28	*	49	46
Black or African American	148	135	76	129	240	274
NHPI	*	*	*	*	*	*
White	1,090	1,072	829	776	2,043	1,828
Two or More Races	29	38	74^a	11	93	75
Hispanic or Latino	328	198	232	174	549	377
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.25B – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2023)	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2024)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2023)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2024)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2023)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2024)
TOTAL	6.1	5.3	4.3	4.1	6.2	5.4
AGE GROUP
12-17	4.8	3.8	3.0	4.2	4.7	3.8
18 or Older	6.2	5.4	4.3	4.1	6.3	5.5
18-25	3.9	3.4	3.7	2.5	4.4	3.6
26 or Older	6.9	6.0	4.5	4.4	6.7	6.0
SEX
Male	5.4	5.4	4.5	3.7	5.7	5.2
Female	7.1	5.2	4.0	4.6	6.8	5.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	5.9	5.5	4.2	4.2	6.1	5.6
AIAN	5.8	7.6	1.2	3.6	4.7	6.2
Asian	3.4	3.0	2.8	*	3.1	2.8
Black or African American	3.8	3.4	2.3	3.8	3.9	4.5
NHPI	*	*	*	*	*	*
White	6.7	6.2	4.5	4.4	6.7	6.0
Two or More Races	3.1	3.4	8.8^a	1.7	6.2	5.1
Hispanic or Latino	7.2	4.1	4.8	3.5	6.7	4.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.26A – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2023)	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2024)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2023)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2024)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2023)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2024)
TOTAL	1,650	1,490	1,241	1,134	3,007	2,628
GEOGRAPHIC REGION
Northeast	372	341	266	164	714	523
Midwest	304	327	235	219	536	507
South	497	483	385	439	937	939
West	478	340	355	311	819	659
COUNTY TYPE
Large Metro	1,033	779	656	688	1,694	1,508
Small Metro	395	465	459	321	929	778
Nonmetro	222	246	126	125	384	342
Urbanized	80	63	35	38	135	82
Less Urbanized	141	177	50	81	207	244
Completely Rural	*	*	*	*	*	16
POVERTY LEVEL²
Less Than 100%	520	599	257	196	784	813
100-199%	390	284	125	190	593	473
200% or More	737	607	858	747	1,627	1,342
HEALTH INSURANCE³
Private	552	598	575	641	1,175	1,198
Medicaid/CHIP	975	775	451	277	1,495^a	1,104
Other⁴	301	337	261	277	649	580
No Coverage	87	106	64	93	161	199
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s). ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.26B – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2023)	Received Telehealth Treatment for Drug Use among People with a Drug Use Disorder (2024)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2023)	Received Telehealth Treatment for Alcohol Use among People with an Alcohol Use Disorder (2024)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2023)	Received Telehealth Treatment for Substance Use among People with a Substance Use Disorder¹ (2024)
TOTAL	6.1	5.3	4.3	4.1	6.2	5.4
GEOGRAPHIC REGION
Northeast	7.3	6.9	5.2	3.5	8.0	6.2
Midwest	5.4	5.4	3.9	3.5	5.3	4.8
South	5.3	4.8	3.6	4.4	5.3	5.4
West	6.9	4.9	5.3	4.5	7.0	5.5
COUNTY TYPE
Large Metro	7.1	5.1	4.0	4.2	6.3	5.5
Small Metro	4.5	5.2	4.9	3.8	5.9	5.2
Nonmetro	6.1	6.5	4.2	4.4	6.5	5.9
Urbanized	5.2	4.0	2.7	3.0	5.5	3.3
Less Urbanized	7.5	8.7	3.3	5.7	6.9	8.2
Completely Rural	*	*	*	*	*	4.8
POVERTY LEVEL²
Less Than 100%	8.4	9.0	6.0	4.4	8.7	8.6
100-199%	6.3	4.3	2.6	4.1	6.4	5.0
200% or More	5.1	4.1	4.3	4.0	5.4	4.6
HEALTH INSURANCE³
Private	4.2	4.4	3.2	3.7	4.3	4.4
Medicaid/CHIP	10.6	8.3	7.8	5.1	11.7	8.8
Other⁴	5.6	6.8	5.0	5.8	6.9	6.6
No Coverage	2.7	2.9	2.1	2.9	3.1	3.6
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s). ² Respondents aged 18 to 22 who were living in a college dormitory were excluded. ³ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁴ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.27A – Types and Locations of Substance Use Treatment and Other Services in Past Year: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2023 and 2024
Type/Location of Treatment or Other Services	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE TREATMENT OR OTHER SERVICES^1,2	--	14,569	--	893	--	13,676	--	1,443	--	12,233
SUBSTANCE USE TREATMENT¹	--	10,174	--	732	--	9,442	--	1,059	--	8,383
Inpatient¹	--	2,603	--	273	--	2,330	--	354	--	1,976
Hospital¹	--	1,297	--	148	--	1,149	--	240	--	910
Residential Drug or Alcohol Rehab or Treatment Center¹	--	1,484	--	74	--	1,410	--	195	--	1,214
Residential Mental Health Treatment Center¹	--	1,232	--	139	--	1,093	--	220	--	873
Some Other Place as an Inpatient¹	--	572	--	93	--	479	--	101	--	378
Outpatient¹	--	7,096	--	456	--	6,640	--	740	--	5,900
Drug or Alcohol Rehab or Treatment Center¹	--	2,328	--	71	--	2,256	--	213	--	2,043
Mental Health Treatment Center¹	--	2,054	--	96	--	1,958	--	241	--	1,717
Office of a Therapist, Psychologist, Psychiatrist, or Substance Use Treatment Professional¹	--	4,178	--	232	--	3,946	--	481	--	3,465
General Medical Clinic or Doctor’s Office¹	--	3,298	--	172	--	3,126	--	260	--	2,866
Hospital¹	--	1,145	--	80	--	1,065	--	112	--	953
School’s Health or Counseling Center¹	--	709	--	218	--	491	--	123	--	368
Some Other Place as an Outpatient¹	--	710	--	35	--	675	--	85	--	590
Outpatient, Other Than General Medical Clinic or Doctor’s Office¹	--	6,118	--	407	--	5,711	--	658	--	5,052
Medications for Alcohol Use Disorder³	1,146	1,309	13^a	51	1,133	1,258	88	123	1,044	1,136
Medications for Opioid Use Disorder⁴	2,296	2,155	37	36	2,258	2,119	99	68	2,159	2,051
Telehealth Treatment⁵	3,979	3,640	158	119	3,820	3,521	469	377	3,352	3,143
Prison, Jail, or Juvenile Detention Center	797	819	42	41	755	779	73	63	682	716
OTHER SERVICES
Support Services
Support Group	5,848	6,104	185	170	5,663	5,934	390	456	5,272	5,478
Peer Support Specialist or Recovery Coach	2,254	2,244	82	50	2,172	2,194	173	161	1,999	2,033
Emergency Room/Department or Withdrawal Management Services
Emergency Room/Department	1,854	1,723	120	89	1,734	1,634	318	293	1,416	1,341
Withdrawal Management Services	1,169	955	48	30	1,121	925	127	89	994	836
Overdose Reversal Medicine (e.g. Narcan® or Naloxone)	--	1,753	--	84	--	1,669	--	149	--	1,520
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Respondents could indicate multiple types/locations for receiving substance use treatment or other services; thus, these response categories are not mutually exclusive. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Other services include treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; withdrawal management services; or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime. ³ Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol. ⁴ Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers. ⁵ Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.27B – Types and Locations of Substance Use Treatment and Other Services in Past Year: Among People Aged 12 or Older; by Age Group, Percentages, 2023 and 2024
Type/Location of Treatment or Other Services	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE TREATMENT OR OTHER SERVICES^1,2	--	5.1	--	3.4	--	5.2	--	4.1	--	5.4
SUBSTANCE USE TREATMENT¹	--	3.5	--	2.8	--	3.6	--	3.0	--	3.7
Inpatient¹	--	0.9	--	1.1	--	0.9	--	1.0	--	0.9
Hospital¹	--	0.4	--	0.6	--	0.4	--	0.7	--	0.4
Residential Drug or Alcohol Rehab or Treatment Center¹	--	0.5	--	0.3	--	0.5	--	0.6	--	0.5
Residential Mental Health Treatment Center¹	--	0.4	--	0.5	--	0.4	--	0.6	--	0.4
Some Other Place as an Inpatient¹	--	0.2	--	0.4	--	0.2	--	0.3	--	0.2
Outpatient¹	--	2.5	--	1.8	--	2.5	--	2.1	--	2.6
Drug or Alcohol Rehab or Treatment Center¹	--	0.8	--	0.3	--	0.9	--	0.6	--	0.9
Mental Health Treatment Center¹	--	0.7	--	0.4	--	0.7	--	0.7	--	0.8
Office of a Therapist, Psychologist, Psychiatrist, or Substance Use Treatment Professional¹	--	1.4	--	0.9	--	1.5	--	1.4	--	1.5
General Medical Clinic or Doctor’s Office¹	--	1.1	--	0.7	--	1.2	--	0.7	--	1.3
Hospital¹	--	0.4	--	0.3	--	0.4	--	0.3	--	0.4
School’s Health or Counseling Center¹	--	0.2	--	0.8	--	0.2	--	0.4	--	0.2
Some Other Place as an Outpatient¹	--	0.2	--	0.1	--	0.3	--	0.2	--	0.3
Outpatient, Other Than General Medical Clinic or Doctor’s Office¹	--	2.1	--	1.6	--	2.2	--	1.9	--	2.2
Medications for Alcohol Use Disorder³	0.4	0.5	0.1^a	0.2	0.4	0.5	0.3	0.4	0.5	0.5
Medications for Opioid Use Disorder⁴	0.8	0.7	0.1	0.1	0.9	0.8	0.3	0.2	1.0	0.9
Telehealth Treatment⁵	1.4	1.3	0.6	0.5	1.5	1.3	1.4	1.1	1.5	1.4
Prison, Jail, or Juvenile Detention Center	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.3
OTHER SERVICES
Support Services
Support Group	2.1	2.1	0.7	0.7	2.2	2.3	1.1	1.3	2.4	2.4
Peer Support Specialist or Recovery Coach	0.8	0.8	0.3	0.2	0.8	0.8	0.5	0.5	0.9	0.9
Emergency Room/Department or Withdrawal Management Services
Emergency Room/Department	0.7	0.6	0.5	0.3	0.7	0.6	0.9	0.8	0.6	0.6
Withdrawal Management Services	0.4	0.3	0.2	0.1	0.4	0.4	0.4	0.3	0.4	0.4
Overdose Reversal Medicine (e.g. Narcan® or Naloxone)	--	0.6	--	0.3	--	0.6	--	0.4	--	0.7
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Respondents could indicate multiple types/locations for receiving substance use treatment or other services; thus, these response categories are not mutually exclusive. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Other services include treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; withdrawal management services; or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime. ³ Medications for alcohol use disorder (MAUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of alcohol. ⁴ Medications for opioid use disorder (MOUD) refer to medications prescribed by a doctor or other health professional to help reduce or stop the use of opioids. Questions for the receipt of MOUD were asked only if respondents reported lifetime use of heroin or prescription pain relievers. ⁵ Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.28A – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Numbers in Thousands, 2023 and 2024
Substance for Which Treatment Was Received and Use Disorder for Specific Substance	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE DISORDER¹	--	1,785	--	104	--	1,681	--	255	--	1,426
DRUGS	--	966	--	56	--	909	--	146	--	763
Marijuana	--	278	--	36	--	242	--	83	--	159
Cocaine	--	64	--	*	--	63	--	15	--	49
Heroin	--	*	--	*	--	*	--	*	--	*
Hallucinogens	--	30	--	*	--	21	--	*	--	*
Inhalants	--	2	--	*	--	*	--	*	--	*
Methamphetamine	--	237	--	*	--	237	--	*	--	193
Prescription Psychotherapeutics	--	322	--	13	--	309	--	44	--	265
Pain Relievers	--	205	--	7	--	198	--	36	--	162
Stimulants	--	45	--	*	--	40	--	15	--	25
Tranquilizers or Sedatives	--	180	--	*	--	172	--	18	--	154
Tranquilizers	--	147	--	*	--	142	--	18	--	123
Sedatives	--	*	--	*	--	*	--	*	--	*
Opioids²	--	331	--	8	--	324	--	48	--	276
Central Nervous System Stimulants	--	325	--	*	--	319	--	63	--	256
ALCOHOL	--	550	--	22	--	528	--	63	--	465
BOTH DRUGS AND ALCOHOL	--	130	--	8	--	122	--	28	--	94
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Includes data from respondents who reported that they received inpatient substance use treatment but did not report the substance(s) for which they received treatment. ² Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.28B – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Percentages, 2023 and 2024
Substance for Which Treatment Was Received and Use Disorder for Specific Substance	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE DISORDER¹	--	3.7	--	5.2	--	3.6	--	2.8	--	3.8
DRUGS	--	3.4	--	3.3	--	3.4	--	2.4	--	3.8
Marijuana	--	1.4	--	3.0	--	1.3	--	1.5	--	1.1
Cocaine	--	5.2	--	*	--	5.3	--	5.2	--	5.3
Heroin	--	*	--	*	--	*	--	*	--	*
Hallucinogens	--	7.0	--	*	--	5.9	--	*	--	*
Inhalants	--	0.7	--	*	--	*	--	*	--	*
Methamphetamine	--	15.1	--	*	--	15.2	--	*	--	13.2
Prescription Psychotherapeutics	--	4.2	--	2.4	--	4.4	--	5.5	--	4.2
Pain Relievers	--	4.1	--	2.4	--	4.2	--	10.5	--	3.7
Stimulants	--	2.5	--	*	--	2.4	--	3.6	--	2.0
Tranquilizers or Sedatives	--	8.6	--	*	--	8.7	--	7.7	--	8.9
Tranquilizers	--	9.8	--	*	--	10.0	--	9.6	--	10.1
Sedatives	--	*	--	*	--	*	--	*	--	*
Opioids²	--	6.9	--	2.8	--	7.1	--	14.4	--	6.5
Central Nervous System Stimulants	--	7.6	--	*	--	7.9	--	8.7	--	7.7
ALCOHOL	--	2.0	--	2.9	--	1.9	--	1.3	--	2.1
BOTH DRUGS AND ALCOHOL	--	1.7	--	1.7	--	1.7	--	1.3	--	1.8
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Includes data from respondents who reported that they received inpatient substance use treatment but did not report the substance(s) for which they received treatment. ² Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.29A – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Numbers in Thousands, 2023 and 2024
Substance for Which Treatment Was Received and Use Disorder for Specific Substance	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE DISORDER¹	--	4,163	--	217	--	3,946	--	540	--	3,406
DRUGS	--	2,071	--	106	--	1,965	--	313	--	1,651
Marijuana	--	626	--	69	--	557	--	173	--	384
Cocaine	--	138	--	*	--	138	--	17	--	120
Heroin	--	153	--	*	--	149	--	*	--	131
Hallucinogens	--	46	--	*	--	*	--	*	--	*
Inhalants	--	*	--	*	--	*	--	*	--	*
Methamphetamine	--	310	--	*	--	310	--	*	--	257
Prescription Psychotherapeutics	--	789	--	32	--	757	--	86	--	671
Pain Relievers	--	505	--	9	--	496	--	44	--	452
Stimulants	--	106	--	16	--	90	--	21	--	69
Tranquilizers or Sedatives	--	286	--	*	--	274	--	*	--	235
Tranquilizers	--	212	--	*	--	203	--	*	--	170
Sedatives	--	101	--	*	--	99	--	*	--	*
Opioids²	--	627	--	13	--	614	--	58	--	556
Central Nervous System Stimulants	--	530	--	16	--	514	--	80	--	434
ALCOHOL	--	1,203	--	47	--	1,156	--	134	--	1,022
BOTH DRUGS AND ALCOHOL	--	289	--	19	--	269	--	58	--	211
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Includes data from respondents who reported that they received outpatient substance use treatment but did not report the substance(s) for which they received treatment. ² Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.29B – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Percentages, 2023 and 2024
Substance for Which Treatment Was Received and Use Disorder for Specific Substance	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
SUBSTANCE USE DISORDER¹	--	8.6	--	10.7	--	8.5	--	6.0	--	9.1
DRUGS	--	7.3	--	6.2	--	7.4	--	5.0	--	8.1
Marijuana	--	3.0	--	5.7	--	2.9	--	3.1	--	2.8
Cocaine	--	11.4	--	*	--	11.5	--	6.2	--	13.1
Heroin	--	30.9	--	*	--	30.7	--	*	--	28.9
Hallucinogens	--	10.6	--	*	--	*	--	*	--	*
Inhalants	--	*	--	*	--	*	--	*	--	*
Methamphetamine	--	19.7	--	*	--	19.8	--	*	--	17.5
Prescription Psychotherapeutics	--	10.3	--	6.1	--	10.7	--	10.7	--	10.6
Pain Relievers	--	10.2	--	3.2	--	10.6	--	12.8	--	10.4
Stimulants	--	5.7	--	8.3	--	5.4	--	5.0	--	5.6
Tranquilizers or Sedatives	--	13.6	--	*	--	13.9	--	*	--	13.6
Tranquilizers	--	14.2	--	*	--	14.4	--	*	--	13.9
Sedatives	--	12.5	--	*	--	12.8	--	*	--	*
Opioids²	--	13.0	--	4.9	--	13.5	--	17.4	--	13.2
Central Nervous System Stimulants	--	12.4	--	7.7	--	12.7	--	11.1	--	13.0
ALCOHOL	--	4.3	--	6.0	--	4.3	--	2.7	--	4.6
BOTH DRUGS AND ALCOHOL	--	3.7	--	4.2	--	3.7	--	2.7	--	4.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Includes data from respondents who reported that they received outpatient substance use treatment but did not report the substance(s) for which they received treatment. ² Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.30A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Past Year Drug Use Disorder, Past Year Alcohol Use Disorder, Past Year Drug and Alcohol Use Disorder, and Past Year Substance Use Disorder, Numbers in Thousands, 2023 and 2024
Substance/Age Group	Treatment for Drugs (2023)	Treatment for Drugs (2024)	Treatment for Alcohol (2023)	Treatment for Alcohol (2024)	Treatment for Both Drugs and Alcohol (2023)	Treatment for Both Drugs and Alcohol (2024)	Treatment for Substance Unspecified¹ (2023)	Treatment for Substance Unspecified¹ (2024)	Treatment for Substance Use¹ (2023)	Treatment for Substance Use¹ (2024)
DRUGS	--	3,140	--	1,400	--	940	--	664	--	4,264
12-17	--	188	--	75	--	51	--	82	--	294
18 or Older	--	2,952	--	1,325	--	888	--	582	--	3,971
18-25	--	453	--	233	--	142	--	86	--	631
26 or Older	--	2,498	--	1,091	--	746	--	496	--	3,340
ALCOHOL	--	1,358	--	2,134	--	812	--	390	--	3,071
12-17	--	117	--	91	--	68	--	30	--	170
18 or Older	--	1,240	--	2,043	--	744	--	361	--	2,901
18-25	--	252	--	271	--	142	--	77	--	459
26 or Older	--	989	--	1,772	--	602	--	283	--	2,442
BOTH DRUGS AND ALCOHOL	--	910	--	771	--	470	--	197	--	1,409
12-17	--	88	--	62	--	43	--	28	--	134
18 or Older	--	822	--	709	--	426	--	169	--	1,275
18-25	--	213	--	182	--	113	--	41	--	323
26 or Older	--	609	--	527	--	313	--	128	--	952
SUBSTANCE USE DISORDER	--	3,588	--	2,762	--	1,282	--	858	--	5,926
12-17	--	218	--	104	--	76	--	84	--	330
18 or Older	--	3,370	--	2,659	--	1,206	--	774	--	5,596
18-25	--	492	--	323	--	171	--	123	--	766
26 or Older	--	2,878	--	2,336	--	1,035	--	651	--	4,830
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.30B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Past Year Drug Use Disorder, Past Year Alcohol Use Disorder, Past Year Drug and Alcohol Use Disorder, and Past Year Substance Use Disorder, Percentages, 2023 and 2024
Substance/Age Group	Treatment for Drugs (2023)	Treatment for Drugs (2024)	Treatment for Alcohol (2023)	Treatment for Alcohol (2024)	Treatment for Both Drugs and Alcohol (2023)	Treatment for Both Drugs and Alcohol (2024)	Treatment for Substance Unspecified¹ (2023)	Treatment for Substance Unspecified¹ (2024)	Treatment for Substance Use¹ (2023)	Treatment for Substance Use¹ (2024)
DRUGS	--	11.1	--	5.0	--	3.3	--	2.4	--	15.1
12-17	--	11.0	--	4.4	--	3.0	--	4.8	--	17.2
18 or Older	--	11.1	--	5.0	--	3.4	--	2.2	--	15.0
18-25	--	7.3	--	3.8	--	2.3	--	1.4	--	10.2
26 or Older	--	12.3	--	5.4	--	3.7	--	2.4	--	16.5
ALCOHOL	--	4.9	--	7.6	--	2.9	--	1.4	--	11.0
12-17	--	15.1	--	11.7	--	8.8	--	3.9	--	21.9
18 or Older	--	4.6	--	7.5	--	2.7	--	1.3	--	10.7
18-25	--	5.0	--	5.4	--	2.8	--	1.5	--	9.1
26 or Older	--	4.5	--	8.0	--	2.7	--	1.3	--	11.0
BOTH DRUGS AND ALCOHOL	--	11.7	--	10.0	--	6.1	--	2.5	--	18.2
12-17	--	19.2	--	13.6	--	9.5	--	6.0	--	29.3
18 or Older	--	11.3	--	9.7	--	5.8	--	2.3	--	17.5
18-25	--	9.8	--	8.3	--	5.2	--	1.9	--	14.8
26 or Older	--	11.9	--	10.3	--	6.1	--	2.5	--	18.6
SUBSTANCE USE DISORDER	--	7.4	--	5.7	--	2.7	--	1.8	--	12.3
12-17	--	10.8	--	5.1	--	3.8	--	4.2	--	16.3
18 or Older	--	7.3	--	5.7	--	2.6	--	1.7	--	12.1
18-25	--	5.4	--	3.6	--	1.9	--	1.4	--	8.5
26 or Older	--	7.7	--	6.3	--	2.8	--	1.7	--	13.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.31A – Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older with Substance Use Disorder in Past Year; by Substance Use Disorder Severity Level and Age Group, Numbers in Thousands, 2023 and 2024
Substance Use Disorder Severity Level/Age Group	Among People Aged 12 or Older with Substance Use Disorder in Past Year
Substance Use Disorder Severity Level/Age Group	Received Substance Use Treatment (SU Tx) (2023)	Received Substance Use Treatment (SU Tx) (2024)	Did Not Receive SU Tx (2023)	Did Not Receive SU Tx (2024)	Received SU Tx or Other Services¹ (2023)	Received SU Tx or Other Services¹ (2024)	Did Not Receive SU Tx or Other Services¹ (2023)	Did Not Receive SU Tx or Other Services¹ (2024)
Any SUD	--	5,926	--	42,425	--	7,501	--	40,850
12-17	--	330	--	1,694	--	383	--	1,641
18 or Older	--	5,596	--	40,731	--	7,119	--	39,209
18-25	--	766	--	8,290	--	995	--	8,061
26 or Older	--	4,830	--	32,441	--	6,124	--	31,147
Mild SUD	--	1,742	--	25,259	--	2,279	--	24,721
12-17	--	85	--	908	--	99	--	893
18 or Older	--	1,657	--	24,351	--	2,180	--	23,829
18-25	--	151	--	4,285	--	224	--	4,212
26 or Older	--	1,506	--	20,067	--	1,956	--	19,617
Moderate SUD	--	1,302	--	9,729	--	1,622	--	9,409
12-17	--	89	--	407	--	107	--	389
18 or Older	--	1,213	--	9,322	--	1,515	--	9,020
18-25	--	158	--	2,269	--	222	--	2,205
26 or Older	--	1,054	--	7,053	--	1,292	--	6,815
Severe SUD	--	2,883	--	7,437	--	3,600	--	6,719
12-17	--	156	--	379	--	176	--	359
18 or Older	--	2,727	--	7,057	--	3,424	--	6,360
18-25	--	457	--	1,736	--	548	--	1,645
26 or Older	--	2,270	--	5,321	--	2,876	--	4,715
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other services include treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; withdrawal management services; or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.31B – Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older with Substance Use Disorder in Past Year; by Substance Use Disorder Severity Level and Age Group, Percentages, 2023 and 2024
Substance Use Disorder Severity Level/Age Group	Among People Aged 12 or Older with Substance Use Disorder in Past Year
Substance Use Disorder Severity Level/Age Group	Received Substance Use Treatment (SU Tx) (2023)	Received Substance Use Treatment (SU Tx) (2024)	Did Not Receive SU Tx (2023)	Did Not Receive SU Tx (2024)	Received SU Tx or Other Services¹ (2023)	Received SU Tx or Other Services¹ (2024)	Did Not Receive SU Tx or Other Services¹ (2023)	Did Not Receive SU Tx or Other Services¹ (2024)
Any SUD	--	12.3	--	87.7	--	15.5	--	84.5
12-17	--	16.3	--	83.7	--	18.9	--	81.1
18 or Older	--	12.1	--	87.9	--	15.4	--	84.6
18-25	--	8.5	--	91.5	--	11.0	--	89.0
26 or Older	--	13.0	--	87.0	--	16.4	--	83.6
Mild SUD	--	6.4	--	93.6	--	8.4	--	91.6
12-17	--	8.5	--	91.5	--	10.0	--	90.0
18 or Older	--	6.4	--	93.6	--	8.4	--	91.6
18-25	--	3.4	--	96.6	--	5.1	--	94.9
26 or Older	--	7.0	--	93.0	--	9.1	--	90.9
Moderate SUD	--	11.8	--	88.2	--	14.7	--	85.3
12-17	--	18.0	--	82.0	--	21.6	--	78.4
18 or Older	--	11.5	--	88.5	--	14.4	--	85.6
18-25	--	6.5	--	93.5	--	9.2	--	90.8
26 or Older	--	13.0	--	87.0	--	15.9	--	84.1
Severe SUD	--	27.9	--	72.1	--	34.9	--	65.1
12-17	--	29.1	--	70.9	--	32.9	--	67.1
18 or Older	--	27.9	--	72.1	--	35.0	--	65.0
18-25	--	20.8	--	79.2	--	25.0	--	75.0
26 or Older	--	29.9	--	70.1	--	37.9	--	62.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other services include treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; withdrawal management services; or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.32A – Classified as Needing Substance Use Treatment: Among People Aged 12 or Older; Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older Classified as Needing Substance Use Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands and Percentages, 2023 and 2024
Demographic Characteristic	Among the Total Population		Among People Classified as Needing Substance Use Treatment (SU Tx)
Demographic Characteristic	Classified as Needing SU Tx (2023)	Classified as Needing SU Tx (2024)	% Who Received SU Tx (2023)	% Who Received SU Tx (2024)	% Who Did Not Receive SU Tx (2023)	% Who Did Not Receive SU Tx (2024)	% Who Received SU Tx or Other Services¹ (2023)	% Who Received SU Tx or Other Services¹ (2024)	% Who Did Not Receive SU Tx or Other Services¹ (2023)	% Who Did Not Receive SU Tx or Other Services¹ (2024)
TOTAL	--	52,599	--	19.3	--	80.7	--	22.3	--	77.7
AGE GROUP
12-17	--	2,426	--	30.2	--	69.8	--	32.4	--	67.6
18 or Older	--	50,173	--	18.8	--	81.2	--	21.9	--	78.1
18-25	--	9,349	--	11.3	--	88.7	--	13.8	--	86.2
26 or Older	--	40,824	--	20.5	--	79.5	--	23.7	--	76.3
SEX
Male	--	30,173	--	18.1	--	81.9	--	21.1	--	78.9
Female	--	22,426	--	21.0	--	79.0	--	24.0	--	76.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	43,434	--	19.7	--	80.3	--	22.6	--	77.4
AIAN	--	396	--	*	--	*	--	*	--	*
Asian	--	1,713	--	10.2	--	89.8	--	13.7	--	86.3
Black or African American	--	6,764	--	20.9	--	79.1	--	24.7	--	75.3
NHPI	--	167	--	*	--	*	--	*	--	*
White	--	32,834	--	19.8	--	80.2	--	22.6	--	77.4
Two or More Races	--	1,560	--	17.7	--	82.3	--	20.2	--	79.8
Hispanic or Latino	--	9,165	--	17.6	--	82.4	--	20.9	--	79.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing substance use treatment if they met DSM-5 criteria for a drug or alcohol use disorder or received treatment for drug or alcohol use. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other services include treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; withdrawal management services; or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.32B – Classified as Needing Substance Use Treatment: Among People Aged 12 or Older; Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older Classified as Needing Substance Use Treatment in Past Year; by Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Among the Total Population		Among People Classified as Needing Substance Use Treatment (SU Tx)
Demographic Characteristic	Classified as Needing SU Tx (2023)	Classified as Needing SU Tx (2024)	% Who Received SU Tx (2023)	% Who Received SU Tx (2024)	% Who Did Not Receive SU Tx (2023)	% Who Did Not Receive SU Tx (2024)	% Who Received SU Tx or Other Services¹ (2023)	% Who Received SU Tx or Other Services¹ (2024)	% Who Did Not Receive SU Tx or Other Services¹ (2023)	% Who Did Not Receive SU Tx or Other Services¹ (2024)
TOTAL	--	18.2	--	19.3	--	80.7	--	22.3	--	77.7
AGE GROUP
12-17	--	9.3	--	30.2	--	69.8	--	32.4	--	67.6
18 or Older	--	19.1	--	18.8	--	81.2	--	21.9	--	78.1
18-25	--	26.8	--	11.3	--	88.7	--	13.8	--	86.2
26 or Older	--	18.0	--	20.5	--	79.5	--	23.7	--	76.3
SEX
Male	--	21.4	--	18.1	--	81.9	--	21.1	--	78.9
Female	--	15.2	--	21.0	--	79.0	--	24.0	--	76.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	18.6	--	19.7	--	80.3	--	22.6	--	77.4
AIAN	--	29.0	--	*	--	*	--	*	--	*
Asian	--	9.2	--	10.2	--	89.8	--	13.7	--	86.3
Black or African American	--	19.2	--	20.9	--	79.1	--	24.7	--	75.3
NHPI	--	13.5	--	*	--	*	--	*	--	*
White	--	19.2	--	19.8	--	80.2	--	22.6	--	77.4
Two or More Races	--	24.1	--	17.7	--	82.3	--	20.2	--	79.8
Hispanic or Latino	--	16.8	--	17.6	--	82.4	--	20.9	--	79.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing substance use treatment if they met DSM-5 criteria for a drug or alcohol use disorder or received treatment for drug or alcohol use. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other services include treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; withdrawal management services; or overdose reversal medicine. Other services questions are asked of respondents who used drugs or alcohol in their lifetime. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.33A – Classified as Needing Alcohol Use Treatment: Among People Aged 12 or Older; Receipt of Alcohol Use Treatment in Past Year: Among People Aged 12 or Older Classified as Needing Alcohol Use Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands and Percentages, 2023 and 2024
Demographic Characteristic	Among the Total Population		Among People Classified as Needing Alcohol Use Treatment (ALC Tx)
Demographic Characteristic	Classified as Needing ALC Tx (2023)	Classified as Needing ALC Tx (2024)	% Who Received ALC Tx (2023)	% Who Received ALC Tx (2024)	% Who Did Not Receive ALC Tx (2023)	% Who Did Not Receive ALC Tx (2024)
TOTAL	--	29,891	--	13.8	--	86.2
AGE GROUP
12-17	--	855	--	20.0	--	80.0
18 or Older	--	29,036	--	13.6	--	86.4
18-25	--	5,186	--	8.3	--	91.7
26 or Older	--	23,850	--	14.7	--	85.3
SEX
Male	--	17,865	--	14.0	--	86.0
Female	--	12,026	--	13.4	--	86.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	24,579	--	14.1	--	85.9
AIAN	--	195	--	*	--	*
Asian	--	1,046	--	8.6	--	91.4
Black or African American	--	3,700	--	16.5	--	83.5
NHPI	--	116	--	*	--	*
White	--	18,817	--	13.8	--	86.2
Two or More Races	--	705	--	11.5	--	88.5
Hispanic or Latino	--	5,312	--	12.0	--	88.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing alcohol use treatment if they met DSM-5 criteria for an alcohol use disorder or received treatment for alcohol use. NOTE: Alcohol use treatment includes treatment for alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Alcohol use treatment questions are asked of respondents who used alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.33B – Classified as Needing Alcohol Use Treatment: Among People Aged 12 or Older; Receipt of Alcohol Use Treatment in Past Year: Among People Aged 12 or Older Classified as Needing Alcohol Use Treatment in Past Year; by Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Among the Total Population		Among People Classified as Needing Alcohol Use Treatment (ALC Tx)
Demographic Characteristic	Classified as Needing ALC Tx (2023)	Classified as Needing ALC Tx (2024)	% Who Received ALC Tx (2023)	% Who Received ALC Tx (2024)	% Who Did Not Receive ALC Tx (2023)	% Who Did Not Receive ALC Tx (2024)
TOTAL	--	10.4	--	13.8	--	86.2
AGE GROUP
12-17	--	3.3	--	20.0	--	80.0
18 or Older	--	11.1	--	13.6	--	86.4
18-25	--	14.8	--	8.3	--	91.7
26 or Older	--	10.5	--	14.7	--	85.3
SEX
Male	--	12.7	--	14.0	--	86.0
Female	--	8.2	--	13.4	--	86.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	10.5	--	14.1	--	85.9
AIAN	--	14.3	--	*	--	*
Asian	--	5.6	--	8.6	--	91.4
Black or African American	--	10.5	--	16.5	--	83.5
NHPI	--	9.4	--	*	--	*
White	--	11.0	--	13.8	--	86.2
Two or More Races	--	10.9	--	11.5	--	88.5
Hispanic or Latino	--	9.7	--	12.0	--	88.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents were classified as needing alcohol use treatment if they met DSM-5 criteria for an alcohol use disorder or received treatment for alcohol use. NOTE: Alcohol use treatment includes treatment for alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Alcohol use treatment questions are asked of respondents who used alcohol in their lifetime. NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.34A – Perceived Unmet Need for Substance Use Treatment in Past Year: Among People Aged 12 to 17 with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Among People Aged 12 to 17 with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year
Demographic Characteristic	Any Perceived Unmet Need (2023)	Any Perceived Unmet Need (2024)	Sought Treatment (2023)	Sought Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2023)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Perceive Need for Substance Use Treatment (2023)	Did Not Perceive Need for Substance Use Treatment (2024)
TOTAL	--	111	--	34	--	77	--	1,537
AGE GROUP
12-13	--	5	--	*	--	3	--	166
14-15	--	32	--	13	--	18	--	407
16-17	--	74	--	18	--	56	--	964
SEX
Male	--	52	--	8	--	44	--	691
Female	--	58	--	26	--	33	--	845
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	80	--	29	--	51	--	1,103
AIAN	--	*	--	*	--	*	--	*
Asian	--	*	--	*	--	*	--	*
Black or African American	--	12	--	*	--	7	--	195
NHPI	--	*	--	*	--	*	--	*
White	--	63	--	21	--	41	--	772
Two or More Races	--	6	--	*	--	3	--	90
Hispanic or Latino	--	31	--	*	--	*	--	434
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.34B – Perceived Unmet Need for Substance Use Treatment in Past Year: Among People Aged 12 to 17 with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Among People Aged 12 to 17 with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year
Demographic Characteristic	Any Perceived Unmet Need (2023)	Any Perceived Unmet Need (2024)	Sought Treatment (2023)	Sought Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2023)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Perceive Need for Substance Use Treatment (2023)	Did Not Perceive Need for Substance Use Treatment (2024)
TOTAL	--	6.7	--	2.0	--	4.6	--	93.3
AGE GROUP
12-13	--	3.1	--	*	--	1.5	--	96.9
14-15	--	7.2	--	3.0	--	4.2	--	92.8
16-17	--	7.1	--	1.7	--	5.4	--	92.9
SEX
Male	--	7.0	--	1.1	--	5.9	--	93.0
Female	--	6.5	--	2.8	--	3.6	--	93.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	6.8	--	2.4	--	4.3	--	93.2
AIAN	--	*	--	*	--	*	--	*
Asian	--	*	--	*	--	*	--	*
Black or African American	--	5.6	--	*	--	3.3	--	94.4
NHPI	--	*	--	*	--	*	--	*
White	--	7.5	--	2.5	--	5.0	--	92.5
Two or More Races	--	5.8	--	*	--	2.7	--	94.2
Hispanic or Latino	--	6.6	--	*	--	*	--	93.4
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.35A – Perceived Unmet Need for Substance Use Treatment in Past Year: Among People Aged 18 or Older with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Among People Aged 18 or Older with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year
Demographic Characteristic	Any Perceived Unmet Need (2023)	Any Perceived Unmet Need (2024)	Sought Treatment (2023)	Sought Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2023)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Perceive Need for Substance Use Treatment (2023)	Did Not Perceive Need for Substance Use Treatment (2024)
TOTAL	--	1,774	--	276	--	1,498	--	38,106
AGE GROUP
18-25	--	359	--	53	--	306	--	7,745
26 or Older	--	1,415	--	223	--	1,192	--	30,361
26-49	--	959	--	121	--	838	--	19,007
50 or Older	--	456	--	102	--	354	--	11,353
SEX
Male	--	1,002	--	168	--	834	--	22,440
Female	--	772	--	108	--	664	--	15,666
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	1,428	--	205	--	1,223	--	31,558
AIAN	--	3	--	1	--	2	--	231
Asian	--	*	--	*	--	*	--	*
Black or African American	--	180	--	31	--	149	--	4,829
NHPI	--	*	--	*	--	*	--	*
White	--	1,157	--	155	--	1,001	--	23,799
Two or More Races	--	70	--	18	--	52	--	1,097
Hispanic or Latino	--	347	--	71	--	275	--	6,548
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.35B – Perceived Unmet Need for Substance Use Treatment in Past Year: Among People Aged 18 or Older with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Among People Aged 18 or Older with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year
Demographic Characteristic	Any Perceived Unmet Need (2023)	Any Perceived Unmet Need (2024)	Sought Treatment (2023)	Sought Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2023)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Perceive Need for Substance Use Treatment (2023)	Did Not Perceive Need for Substance Use Treatment (2024)
TOTAL	--	4.4	--	0.7	--	3.8	--	95.6
AGE GROUP
18-25	--	4.4	--	0.7	--	3.8	--	95.6
26 or Older	--	4.5	--	0.7	--	3.8	--	95.5
26-49	--	4.8	--	0.6	--	4.2	--	95.2
50 or Older	--	3.9	--	0.9	--	3.0	--	96.1
SEX
Male	--	4.3	--	0.7	--	3.6	--	95.7
Female	--	4.7	--	0.7	--	4.0	--	95.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	4.3	--	0.6	--	3.7	--	95.7
AIAN	--	1.3	--	0.4	--	0.9	--	98.7
Asian	--	*	--	*	--	*	--	*
Black or African American	--	3.6	--	0.6	--	3.0	--	96.4
NHPI	--	*	--	*	--	*	--	*
White	--	4.6	--	0.6	--	4.0	--	95.4
Two or More Races	--	6.0	--	1.5	--	4.5	--	94.0
Hispanic or Latino	--	5.0	--	1.0	--	4.0	--	95.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.36A – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year: Among People Aged 18 or Older Who Did Not Receive Substance Use Treatment and Had a Perceived Unmet Need for Substance Use Treatment in Past Year; Numbers in Thousands, 2023 and 2024
Reason for Not Receiving Substance Use Treatment	Total (2023)	Total (2024)
Thought It Would Cost Too Much	--	846
Did Not Have Health Insurance Coverage for Drug or Alcohol Use Treatment	--	560
Health Insurance Would Not Pay Enough of Costs for Treatment	--	453
Did Not Know How or Where to Get Treatment	--	742
Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to	--	643
No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to	--	129
Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times that Worked for Them	--	385
Did Not Have Enough Time for Treatment	--	827
Worried That Information Would Not Be Kept Private	--	622
Worried about What People Would Think or Say if They Got Treatment	--	837
Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children	--	653
Not Ready to Start Treatment	--	1,228
Not Ready to Stop or Cut Back Using Drugs or Alcohol	--	1,094
Thought They Should Have Been Able to Handle Their Drug or Alcohol Use on Their Own	--	1,435
Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment	--	345
Thought They Would Be Forced to Stay in Rehab or Treatment against Their Will	--	340
Did Not Think Treatment Would Help Them	--	554
Thought No One Would Care if They Got Better	--	309
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Respondents could indicate multiple reasons for not receiving substance use treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving substance use treatment data were excluded. NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250602

Table 5.36B – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year: Among People Aged 18 or Older Who Did Not Receive Substance Use Treatment and Had a Perceived Unmet Need for Substance Use Treatment in Past Year; Percentages, 2023 and 2024
Reason for Not Receiving Substance Use Treatment	Total (2023)	Total (2024)
Thought It Would Cost Too Much	--	42.3
Did Not Have Health Insurance Coverage for Drug or Alcohol Use Treatment	--	30.1
Health Insurance Would Not Pay Enough of Costs for Treatment	--	24.6
Did Not Know How or Where to Get Treatment	--	37.5
Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to	--	33.4
No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to	--	7.0
Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times that Worked for Them	--	19.9
Did Not Have Enough Time for Treatment	--	42.3
Worried That Information Would Not Be Kept Private	--	31.7
Worried about What People Would Think or Say if They Got Treatment	--	41.8
Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children	--	33.0
Not Ready to Start Treatment	--	62.0
Not Ready to Stop or Cut Back Using Drugs or Alcohol	--	56.1
Thought They Should Have Been Able to Handle Their Drug or Alcohol Use on Their Own	--	72.1
Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment	--	17.4
Thought They Would Be Forced to Stay in Rehab or Treatment against Their Will	--	17.6
Did Not Think Treatment Would Help Them	--	29.4
Thought No One Would Care if They Got Better	--	16.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medications for alcohol or opioid use disorder; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Respondents could indicate multiple reasons for not receiving substance use treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving substance use treatment data were excluded. NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.